Stockwinners Market Radar for July 19, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
DXC... | Hot Stocks19:04 EDT DXC Technology unit enters Master Accounts Receivable Purchase Agreement - According to a regulatory filing, on July 14, 2017, DXC Technology subsidiary Enterprise Services LLC entered into a Master Accounts Receivable Purchase Agreement, among the Seller, The Bank of Tokyo Mitsubishi UFJ (MTU), New York Branch, as administrative agent, and BTMU, The Bank of Nova Scotia (BNS) and Mizuho Bank (MFG), as purchasers. Concurrently, the company entered into a Guaranty made in favor of the Agent, that guarantees the obligations of the Seller. The structured transaction results in the continuous non-recourse true sale of eligible receivables. The Purchase Agreement establishes a federal government obligor receivables purchase facility that provides for up to $200M in funding based on the availability of eligible receivables and the satisfaction of certain conditions. The Facility Limit may be increased from time to time pursuant to the terms of the Purchase Agreement. The Facility is a committed facility that has an initial term of one year, unless terminated earlier by the Seller, the Agent or the Purchasers. The Purchase Agreement also provides for optional extensions of the Facility's term, if agreed to by the Purchasers, in each case for an additional six month duration. Each such extension may be requested as early as 210 days prior to, and not less than sixty days prior to, the then scheduled termination date. Under the Facility, the Seller will sell eligible federal government obligor receivables, including both receivables that have already been billed under an invoice and also certain unbilled receivables arising from contracts where the Seller has performed work under a "cost plus fixed fee" or "time and materials" contract and other required conditions.
|
SJM | Hot Stocks18:59 EDT J.M. Smucker raises quarterly dividend 4% to 78c from 75c per share - The dividend will be paid on Friday, September 1 to shareholders of record at the close of business on Friday, August 11.
|
AMBC | Hot Stocks18:43 EDT Ambac Financial reaches agreement on segregated account rehabilitation - Ambac Financial has entered into a rehabilitation exit support agreement with a group of holders of beneficial interests in Deferred Amounts of the Segregated Account of AAC and AAC surplus notes due 2020 regarding a holistic restructuring transaction designed to facilitate the conclusion of the rehabilitation of the Segregated Account. AAC has also received confirmation from the Office of the Commissioner of Insurance for the State of Wisconsin of its support for the Transaction and its intention to move forward with an amendment to the Plan of Rehabilitation for the Segregated Account to conclude the rehabilitation of the Segregated Account. The transaction consists of three main components, which in the aggregate satisfy the OCI's regulatory capital requirements for the Segregated Account's exit from rehabilitation. The Amendment and Exchange Transactions, if consummated, include a 6.5% discount and would provide to AAC and third party holders of beneficial interests in DPOs and General Account Surplus Notes, an effective consideration package totaling 93.5% of each dollar of accretive value. If consummated, the Transaction will on a pro forma basis result in an increase of approximately $361.1M or $8.02 of Book Value per share and approximately $461.4M or $9.83 of Adjusted Book Value per share. The Supporting Holders represent over 50% of the principal amount outstanding of General Account Surplus Notes, and 34% of the DPOs, in each case held by third parties and have agreed to support the Transaction. If all conditions are met, the Amendment, Exchange Transactions and the issuance of the Tier 2 Notes are anticipated to close during Q4.
|
ZEN AMZN | Hot Stocks18:30 EDT Zendesk announces enhanced data service capabilities in Australia - Zendesk (ZEN) announced plans to launch a new data centre pod in Sydney to serve the needs of its rapidly growing base of customers in Australia and New Zealand. The expanded cloud capabilities will provide Zendesk customers with enhanced security, resilience, and performance under a secure Amazon Web Services (AMZN) environment. The Australian cloud implementation will be live from August 2017, joining Zendesk's other data centres in Germany, Ireland, Japan, and the US which use a hybrid of AWS, Google Cloud Platform and managed colocation data centres.
|
STLD | Hot Stocks18:03 EDT Steel Dynamics CEO sees North American steel consumption 'steady' - CEO Mark Millet said, "We remain optimistic that macroeconomic and market conditions are in place to benefit domestic steel consumption in the coming years. Although U.S. automotive production has peaked, we believe North American automotive steel consumption will be steady, and that there will be additional growth in the energy and construction sectors, especially for larger, public sector infrastructure projects. We continue to strengthen our financial position through strong cash flow generation and the execution of our long-term strategy. We are well-positioned for growth, and remain focused on delivering shareholder value through organic and strategic growth opportunities."
|
SWK | Hot Stocks17:56 EDT Stanley Black & Decker raises quarterly dividend to 63c from 58c per share - This marks the 50th consecutive annual dividend increase for the company. The dividend is payable on Tuesday, September 19 to shareholders of record as of the close of business on Friday, September 1.
|
KMI | Hot Stocks17:49 EDT Kinder Morgan backs FY17 adjusted EBITDA view of about $7.2B - For 2017, KMI's budget was to declare dividends of $0.50 per share, achieve DCF of approximately $4.46 billion and Adjusted EBITDA of approximately $7.2 billion. KMI also budgeted to invest $3.2 billion in growth projects during 2017, to be funded with internally generated cash flow without the need to access equity markets, and to end the year with a net debt-to-Adjusted EBITDA ratio of approximately 5.4 times. As a result of the successful IPO of its Canadian assets, KMI now expects to end the year with a net debt-to-Adjusted EBITDA ratio of approximately 5.2 times, growth capital investment of $3.1 billion and DCF less than 1 percent below budget. The $3.1 billion in growth capital does not include KML-related expansion capex as KMI expects KML to be a self-funding entity and does not anticipate making such contributions. Excluding the impact of KMI's sale of a 30 percent interest in its Canadian assets in the IPO, DCF is forecast to be on plan. KMI does not provide budgeted net income attributable to common stockholders due to the inherent difficulty and impracticality of predicting certain amounts required by GAAP, such as ineffectiveness on commodity, interest rate and foreign currency hedges, unrealized gains and losses on derivatives marked to market, and potential changes in estimates for certain contingent liabilities. KMI's expectations assume average annual prices for West Texas Intermediate crude oil of $53 per barrel and Henry Hub natural gas of $3 per MMBtu, consistent with forward pricing during the company's budget process. The vast majority of cash KMI generates is fee-based and therefore not directly exposed to commodity prices. The primary area where KMI has commodity price sensitivity is in its CO2 segment, with the majority of the segment's next 12 months of oil and NGL production hedged to minimize this sensitivity. The segment is currently hedged for 34,920 barrels per day (Bbl/d) at $58.91 per barrel for the remainder of the year, as well as 21,192 Bbl/d at $60.76/Bbl in 2018; 11,600 Bbl/d at $55.93/Bbl in 2019; 6,700 Bbl/d at $53.28/Bbl in 2020; and, 1,800 Bbl/d at $52.72/Bbl in 2021. For its 2017 budget, the company estimates that every $1 per barrel change in the average WTI crude oil price impacts distributable cash flow by approximately $6 million and each $0.10 per MMBtu change in the price of natural gas impacts distributable cash flow by approximately $1 million.
|
CMG | Hot Stocks17:44 EDT Hedge fund manager Bill Ackman tweets photo of himself ordering at Chipotle - Ackman tweeted, "Eating our own cooking @ ChipotleTweets and making my own mix at savorwavs.com." In September of 2016, Ackman reported a 9.9% stake in Chipotle. In the filing at the time, Pershing said it intended to engage in discussions with Chipotle's board and management. Pershing said at the time that the stock is undervalued and attractive. Shares of Chipotle are lower by .05% in late day trading as advances are made in broader market indices, after the fast-casual restaurant company's latest food scare. Reference Link
|
CHFC | Hot Stocks17:40 EDT Chemical Financial raises quarterly dividend 3.7% to 28c per share
|
GE | Hot Stocks17:39 EDT General Electric awarded $409M government contract - General Electric Co., Cincinnati, Ohio, has been awarded a not-to-exceed $409M indefinite-delivery/indefinite-quantity contract for next generation thermal, power, and controls. The contract for the NGT-PAC program, which is a multiple government agency and industry joint effort to develop revolutionary and innovative technologies by the 2024 timeframe that will conduct applied research to increase knowledge and understanding of future power, thermal and controls requirements while advancing technology development, in an effort to prove technological feasibility and assess operability and producibility of thermal, power, and controls components and architectures through proof of principal demonstrations. Work will be performed in Cincinnati, Ohio, and is expected to be completed by July 2024. This award is the result of a competitive acquisition, and seven offers were received. No specific funds are being obligated on the basic IDIQ, although, in conjunction with the basic IDIQ award, task order 1 is fully funded with fiscal year 2017 research and development funds in the amount of $106,244 at time of award. Air Force Research Laboratory, Wright- Patterson Air Force Base, Ohio, is the contracting activity.
|
SRPT... | Hot Stocks17:34 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: Sarepta (SRPT), up 14.5%... Plexus (PLXS), up 6.5%... Datawatch (DWCH), up 4.7%... United Rentals (URI), up 3.6%... T-Mobile (TMUS), up 2.9%. ALSO HIGHER: Highpower International (HPJ), up 26.8% after it reported preliminary Q2 net sales that marked a 36%-42% increase from the same quarter a year ago... Avista (AVA), up 19% after it agreed to be acquired by Hydro One for $53 per share in a $5.3B all-cash transaction... Kinder Morgan (KMI), up 3.7% after it announced an expected 60% dividend increase for 2018 and authorized a $2B share buyback program... Nike (NKE), up 2.1% after the stock was upgraded to Overweight form Equal Weight at Morgan Stanley... Mylan (MYL), up 0.7% after it and Theravance Biopharma (TBPH) announced "positive" results from a 12-month Phase 3 safety study of revefenacin. DOWN AFTER EARNINGS: PTC (PTC), down 12.2%... C.H. Robinson (CHRW), down 8%... Qualcomm (QCOM), down 1.7%... American Express (AXP), down 1.4%... Crown Holdings (CCK), down 0.3%. ALSO LOWER: Aerie Pharmaceuticals (AERI), down 5.6% after reporting 'successful' 12-month safety results of its "Mercury 1" Phase 3 registration trial for Roclatan... Gladstone (GOOD), down 5% after it filed to sell common stock... Bunge (BG), down 3.4% after it launched a cost reduction program and guided for "modestly profitable" earnings per share for the second quarter.
|
SEDG | Hot Stocks17:33 EDT Integrated Core Strategie lowers passive stake in SolarEdge to 3%
|
RSYS | Hot Stocks17:25 EDT Nierenberg lowers stake in RadiSys to 4.1% from 6.9%
|
RMD... | Hot Stocks17:22 EDT ResMed, Packaging Corp., A.O. Smith, Duke set to join S&P 500 at open on 7/26 - S&P MidCap 400 constituents ResMed (RMD), Packaging Corporation of America (PKG), A.O. Smith Corp. (AOS) and Duke Realty Corp. (DRE) will replace Mallinckrodt (MNK), Murphy Oil (MUR), Bed Bath & Beyond (BBBY) and Transocean (RIG) respectively, in the S&P 500 effective prior to the open of trading on Wednesday, July 26 . Mallinckrodt, Murphy Oil, Bed Bath & Beyond and Transocean will replace ResMed, Packaging Corporation of America, A.O. Smith and Duke Realty, respectively in the S&P MidCap 400. All stocks moving to the S&P 500 have total market capitalizations above $10B making them more representative of the large-cap market space. All stocks moving to the S&P MidCap 400 have total market capitalizations below $4.5B making them more representative of the mid-cap market space.
|
AA | Hot Stocks17:18 EDT Alcoa backs prior shipments guidance for all three segments
|
MGM... | Hot Stocks17:18 EDT MGM Resorts to replace Reynolds American in S&P 500 at open on 7/26 - British American Tobacco (BTI) is acquiring Reynolds American (RAI) in a deal expected to be completed on July 25, pending final conditions.
|
RRR | Hot Stocks17:16 EDT Point72 reports 5.1% passive stake in Red Rock Resorts
|
AA | Hot Stocks17:12 EDT Alcoa sees FY17 net performance outlook of negative $50M - Alcoa says stronger markets pressuring costs; 2017 net performance outlook of negative $50M.
|
AA | Hot Stocks17:09 EDT Alcoa note that china needs to work harder to reduce supplies - Comments from Q2 earnings call.
|
EGN | Hot Stocks16:57 EDT Corvex raises stake in Energen to 8.8% - Corvex intend to review their investment in Energen on a continuing basis and may from time to time and at any time in the future depending on various factors, including, without limitation, Energen's financial position and strategic direction, actions taken by the Board, price levels of the Shares, other investment opportunities available to the Corvex, conditions in the securities market and general economic and industry conditions, take such actions with respect to their investments in the Issuer as they deem appropriate. These actions may include, without limitation: (i) acquiring additional Shares and/or other equity, debt, notes, other securities, or derivative or other instruments that are convertible into Shares, or are based upon or relate to the value of the Shares or Energen in the open market or otherwise; (ii) disposing of any or all of their Securities in the open market or otherwise; (iii) engaging in any hedging or similar transactions with respect to the Securities; or (iv) proposing or considering one or more of the actions.
|
FOXF | Hot Stocks16:56 EDT Van Berkom & Associates reports 4.58% passive stake in Fox Factory
|
PRCP | Hot Stocks16:49 EDT Perceptron to settle litigation with 3CEMS - Perceptron announced it has entered into an agreement to settle the civil suit filed by 3CEMS, a Cayman Islands and People's Republic of China corporation, in January 2015. The settlement will result in a one-time, 11c per share charge to the company's fiscal fourth quarter and full year 2017 results. Under the terms of the agreement, the company will pay 3CEMS $1M over the course of the next 10 months in return for dismissal and release of all claims. Perceptron will record a reserve for the settlement payments, which will result in a pre-tax charge of $1M in the fiscal fourth quarter of 2017. As part of the agreed settlement, the company denied that it had liability to 3CEMS for the claims raised in this matter.
|
CHRW | Hot Stocks16:45 EDT CH Robinson Worldwide trading resumes
|
BSET | Hot Stocks16:44 EDT Bassett Furniture announces new division to expand Club Level product line - Bassett Furniture Industries announced the formation of a new division to expand its motion product line. The Club Level Motion Division will be led by Bruce Cohenour, senior vice president of sales and merchandising, and will focus on expanding the motion product line nationally with its independent retailers. "Bassett continues to seek new avenues to pursue sales growth as we look to the future. We believe that heightening our commitment to the motion category through our new Club Level Motion Division will enhance our open market sales efforts and offers a strategic complement to our HGTV HOME Design Studios and our Bassett Home Furnishings store program," said Robert H. Spilman Jr., chairman and chief executive officer. The new Club Level program offers fashion-forward styling, 17 leather options, and quick availability to retailers. Other features of Club Level include the use of 100% top grain leathers, a 400-pound weight capacity, and limited lifetime warranty. In addition, the line features powered headrests, extended footrests, and lay flat motion. To support the sales effort for this new division, Bassett will add sales representatives, expand its showroom space in High Point, N.C., this fall, and showcase the new line at the upcoming World Market Center in Las Vegas. "The new Club Level Division enables us to leverage our well-known Bassett brand name to boost visibility of these motion products," said Mr. Cohenour. "For 115 years, Bassett has grown and evolved in the home furnishings industry. This new motion line of furniture will allow us to grow this category with independent furniture retailers and contribute meaningfully to our business."
|
AVA | Hot Stocks16:41 EDT Avista acquired by Hydro One for $53 per share - Hydro One Limited and and Avista jointly announced a definitive merger agreement under which Hydro One will acquire Avista for $53 per share in a $5.3B all-cash transaction. Together, Hydro One and Avista will create a North American leader in regulated electricity and natural gas business with over $25.4B in combined assets. The transaction brings together two industry-leading regulated utilities with over 230 years of collective operational experience as well as shared corporate cultures and values. The combined entity will safely and reliably serve more than two million retail and industrial customers and hold assets throughout North America including Ontario, Washington, Oregon, Idaho, Montana and Alaska. "This marks a proud moment for Canadian champions as we grow our business into a North American leader," said Mayo Schmidt, President and CEO, Hydro One Limited. "This transaction demonstrates the power and value of the transition into an investor-owned utility, by allowing for healthy expansion into new lines of regulated utility business and new jurisdictions, such as the U.S. Pacific Northwest which is experiencing customer and economic growth." "With a focus on operational excellence and building our earnings streams, we are positioned for long-term, sustainable growth," said Schmidt. "We are further accomplishing this goal by bringing together two companies with shared cultures and industry expertise to create a North American regulated utility leader. This combination means greater scale, diversity and financial flexibility." Hydro One has a uniquely strong track record consolidating electricity utilities. Since the IPO, Hydro One has also delivered on cost savings and efficiencies for shareholders and customers. Through the company's energy conservation programs, Hydro One has helped customers and municipalities save 700 GWh year-to-date. "Since our initial public offering, we have significantly enhanced our current operations while exploring opportunities that extend and diversify our regulated assets," said Schmidt. "We constantly seek to deliver exceptional value to shareholders, customers, and the communities we serve through stable, increasing regulated returns, exceptional service, and community engagement." This strategic combination demonstrates the value of consolidation by bringing together two highly complementary platforms to create one of North America's largest regulated utilities, meaningfully enhancing both shareholder and customer value. In addition, over time, non-headcount efficiencies will be realized through collaboration and sharing of best practices on IT, innovation and supply chain purchasing, all of which will further enhance cost savings. No workforce reductions are anticipated as a result of this transaction for either Avista or Hydro One.
|
PAC | Hot Stocks16:39 EDT GAP Airports sees FY17 CapEx 2.5B pesos - Sees FY17 traffic up 11%, plus or minus 1%. Sees FY17 total revenue up 17%, plus or minus 1%. Sees FY17 EBITDA up 16%, plus or minues 1%.
|
POL | Hot Stocks16:37 EDT PolyOne sells its Designed Structures and Solutions business for $115M - PolyOne completed the previously announced sale of its Designed Structures and Solutions business, which includes sheet, rollstock and packaging assets, to Arsenal Capital Partners for $115M. Proceeds from the sale have been used to fund the recent acquisitions of Rutland and Mesa.
|
GLW | Hot Stocks16:37 EDT Corning acquires SpiderCloud Wireless - Corning announced it has acquired SpiderCloud Wireless, a provider of in-building wireless solutions. Terms of the agreement were not disclosed. SpiderCloud, based in Milpitas, California, develops scalable small-cell network platforms that deliver unprecedented coverage and capacity for wireless services inside buildings. Small cells are deployed by mobile operators and enterprises to optimize network efficiency and improve user experience.
|
AVA | Hot Stocks16:35 EDT Hydro One to acquire Avista for $53 per share in $5.3B all-cash transaction - Hydro One and Avista jointly announced a definitive merger agreement under which Hydro One will acquire Avista for $53 per share in a $5.3B all-cash transaction. Together, Hydro One and Avista will create a North American leader in regulated electricity and natural gas business with over $25.4B in combined assets. The transaction brings together two industry-leading regulated utilities with over 230 years of collective operational experience as well as shared corporate cultures and values. The combined entity will safely and reliably serve more than two million retail and industrial customers and hold assets throughout North America including Ontario, Washington, Oregon, Idaho, Montana and Alaska. No workforce reductions are anticipated as a result of this transaction for either Avista or Hydro One. Following completion of the transaction, Avista will maintain its existing corporate headquarters in Spokane and will continue to operate as a standalone utility in Washington, Oregon, Idaho, Montana and Alaska. Its management team and employees will remain in place and it will operate with its own Board of Directors representing the interests of the Pacific Northwest and the communities it serves. The combined company's headquarters will be based in Toronto. The transaction was unanimously approved by the Boards of Directors of both companies and is expected to close in the second half of 2018.
|
TMUS | Hot Stocks16:35 EDT T Mobile trading resumes
|
AKRX | Hot Stocks16:33 EDT Akorn shareholders approve of merger agreement with Kabi - Akorn announced that its shareholders, at a special meeting, have overwhelmingly voted to approve the previously announced merger agreement providing for the acquisition of Akorn by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA. The transaction remains subject to regulatory approvals and customary closing conditions, and the companies expect the acquisition will close by early 2018.
|
AVA | Hot Stocks16:33 EDT Hydro One to acquire Avista for $53 per share in $5.3B all-cash transaction
|
VLP | Hot Stocks16:32 EDT Valero Energy Partners increases quarterly distribution 6.4% - The board of Valero Energy Partners, the general partner of Valero Energy Partners, has approved the Partnership's Q2 cash distribution of 45.5c per unit. This distribution represents a 6.4% increase over the Partnership's previous quarterly distribution. The distribution is payable on August 10 to unitholders of record at the close of business on August 1.
|
SRPT | Hot Stocks16:32 EDT Sarepta up 8.9% after better-than-expected quarterly results
|
LMRK | Hot Stocks16:31 EDT Landmark Infrastructure increases quarterly distribution - Landmark Infrastructure Partners announced that the board of its general partner declared a cash distribution of 35.5c per common unit, or $1.42 per common unit on an annualized basis, for the quarter ended June 30. This quarter's cash distribution, which represents a 6.8% increase year-over-year, marks the tenth consecutive quarter that the Partnership has increased its quarterly cash distribution since its IPO in November 2014. The distribution is payable on August 14 to common unitholders of record as of August 1.
|
MDWD | Hot Stocks16:30 EDT BARDA upsizes contract with MediWound, exercises option related to NexoBrid - MediWound announces that the U.S. Biomedical Advanced Research and Development Authority,BARDA, has upsized its awarded contract with MediWound and exercised an option to fund further research and development activities relating to NexoBrid. Under the modified signed contract, BARDA increased its committed funds to support NexoBrid R&D activities by $32M to approximately $56M, up from the original $24M. BARDA maintains an additional option to further fund $10M in development activities for other potential NexoBrid indications. The contract also maintains BARDA's $16 million commitment for procurement of NexoBrid, which is contingent upon the U.S. Food and Drug Administration Emergency Use Authorization and/or FDA marketing authorization for NexoBrid, as well as BARDA's $50M option for additional procurement of NexoBrid. As a result of the exercise of BARDA's option, total non-dilutive funding to MediWound under the BARDA contract is now valued at up to $132M. The BARDA contract serves to advance the development and manufacturing, as well as the procurement of NexoBrid, MediWound's proprietary pharmaceutical product for enzymatic removal of eschar in deep-partial and full-thickness thermal burns, as a medical countermeasure for preparedness for mass casualty events. The upsized BARDA contract will fund the previously committed development activities to support the submission of a Biologic License Application to the FDA for NexoBrid for the use in thermal burn injuries. In addition, BARDA will now fund the Company's ongoing pediatric phase 3 study and its planned expansion to include U.S. pediatric burn care sites, as well as additional NexoBrid development efforts.
|
TBPH MYL | Hot Stocks16:28 EDT Theravance Biopharma, Mylan: 'Positive' data from Phase 3 study of TD-4208 - Theravance Biopharma (TBPH) and Mylan (MYL) announced positive results from a 12-month Phase 3 safety study of revefenacin (TD-4208), an investigational long-acting muscarinic antagonist and a proposed once-daily, nebulized bronchodilator in development for the treatment of chronic obstructive pulmonary disease. The study of 1,055 patients with COPD demonstrated that revefenacin was generally well-tolerated, and no new safety issues were identified. Rates of adverse events and serious adverse events were low and comparable to those seen in the standard of care treatment arm. The data from these studies, combined with the results will support the submission of the new drug application for revefenacin with the U.S. FDA, anticipated in the fourth quarter of 2017.
|
MYOV | Hot Stocks16:26 EDT Myovant Sciences announces four leadership appointments - Myovant Sciences has appoined four management hires. Matthew Lang has joined the company as General Counsel and Corporate Secretary; Juan Camilo Arjona Ferreira has joined as Chief Medical Officer; Teresa Perney has joined as Senior VP of Regulatory Affairs and Quality Assurance; and Andria Langenberg has joined as Head of Drug Safety and Pharmacovigilance. Lang was previously Vice President, Head of Global Litigation, Investigations, Employment Law and Information Governance at Gilead Sciences. Arjona Ferreira was previously Senior Vice President, Clinical Development at Shionogi. Perney was previously Medicine Team Leader for XTANDI and talazoparib at Pfizer. Langenberg was previously VP of Drug Safety and Pharmacovigilance at Medivation.
|
EBS GSK | Hot Stocks16:25 EDT Emergent BioSolutions to buy raxibacumab from GlaxoSmithKline - Emergent BioSolutions (EBS) announced that it has entered into an agreement with GSK (GSK), one of the world's leading healthcare companies, to acquire raxibacumab, a fully human monoclonal antibody approved by the U.S. Food and Drug Administration for the treatment and prophylaxis of inhalational anthrax. Emergent also plans to assume responsibility for a multi-year contract with the Biomedical Advanced Research and Development Authority, BARDA, valued at up to approximately $130M, to supply the product to the U.S. Strategic National Stockpile. The all-cash transaction consists of a $76Mn upfront payment and up to $20M in product sale and manufacturing-related milestone payments, all of which would likely become due in 2019. Emergent expects to purchase product from GSK to fulfill deliveries to the SNS under the current BARDA contract and plans to transfer raxibacumab manufacturing to existing Emergent facilities in Baltimore, Maryland in 2020. Upon the closing of the transaction, Emergent will: Acquire raxibacumab, including corresponding product rights, regulatory approvals and intellectual property rights; and Plan to assume responsibility for an existing contract with BARDA, a division of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, with a delivery order performance period through November 2019 to supply raxibacumab to the SNS, with a remaining value of up to approximately $130M. Emergent expects to fulfill the deliveries of raxibacumab to the SNS by the end of 2019 under the current BARDA contract, subject to the availability of funding, and expects to negotiate a follow-on contract with the U.S. government to ensure the uninterrupted supply of this critical medical countermeasure to the SNS. Under the terms of the acquisition agreements, Emergent expects to purchase product from GSK to enable completion of deliveries to the SNS under the existing BARDA procurement contract.
|
TLLP | Hot Stocks16:22 EDT Tesoro Logistics increases quarterly distribution 3.3% - Tesoro Logistics announced the declaration of its quarterly cash distribution for Q2 of 97.1c per limited partnership unit, or $3.884 on an annualized basis. This distribution represents a 3.3% increase over the quarterly distribution of 94c per unit, or $3.76 per unit on an annualized basis, paid in May 2017. The Q2 distribution will be paid August 14 to all unitholders of record as of August 4.
|
BCEI | Hot Stocks16:21 EDT Mangrove Partners Master Fund reports 7.6% stake in Bonanza Creek
|
QCOM AAPL | Hot Stocks16:19 EDT Qualcomm says not providing Q3 QTL business metrics due to Apple disupte - Management said, "As a result of the recent actions taken by Apple's (AAPL) contract manufacturers and the other licensee in dispute, we currently do not believe total reported device sales and related estimated ranges of device shipment and average selling price are meaningful in measuring our QTL business, and therefore, we are not providing such metrics for the fiscal third quarter."
|
WFM AMZN | Hot Stocks16:19 EDT JANA Partners liquidates stake in Whole Foods - JANA Partners, which disclosed that it took an 8.3% stake in Whole Foods in April urging it to address chronic underperformance for shareholders, change the board and senior management, optimize real estate and capital allocation strategies and pursue opportunities to improve performance, has liquidated its stake in the grocer and no longer holds any shares, according to a regulatory filing. JANA sold its shares in Whole Foods over the period of June 19 to July 18, the filing shows. Amazon (AMZN) announced on June 16 that it had agreed to acquire Whole Foods for $13.7B.
|
HGV BX | Hot Stocks16:18 EDT Hilton Grand Vacations, Blackstone form JV to purchase timeshare resort - Hilton Grand Vacations (HGV) announced the formation of a joint venture with affiliates of Blackstone (BX) Real Estate Partners VIII L.P., which purchased Elara, a Hilton Grand Vacations Club. With 1,201 units, Elara is one of the world's largest timeshare resorts. HGV will assume a 25% stake in the joint venture for approximately $40M, which is expected to be accretive to HGV's total adjusted EBITDA and EPS. In addition to its ownership stake, HGV will continue to market, sell and manage Elara under existing fee-for-service agreements. The joint-venture structure allows HGV to generate strong returns while maintaining flexibility for additional growth opportunities. The transaction is expected to be funded by existing cash on HGV's balance sheet.
|
QCOM | Hot Stocks16:16 EDT Qualcomm sees Q4 QTL revenue $1B-$1.3B, down 31%-47% y/y
|
QCOM | Hot Stocks16:15 EDT Qualcomm down 2.5% after earnings, guidance
|
GBNK | Hot Stocks16:14 EDT Guaranty Bancorp to acquire Castle Rock Bank Holding - The company announces the signing of a definitive purchase agreement with Castle Rock Bank Holding Company, the holding company for Castle Rock Bank, in an all-stock transaction. Castle Rock Bank, a 43 year old community bank based in Castle Rock, Colorado, has $147.8 million in total assets as of June 30, 2017 and two bank branches strategically located between Denver and Colorado Springs, Colorado. The deal is subject to normal regulatory approvals and customary closing conditions and is expected to close in the first quarter of 2018. Following the close of the transaction, Castle Rock Bank will be merged into Guaranty Bank and Trust and all Castle Rock Bank branches will operate under the Guaranty Bank and Trust name. The Company expects the transaction to be $0.04 accretive to earnings per share in 2018 and have an internal rate of return in excess of 19%. Further information regarding the transaction can be found in the investor presentation filed as an exhibit to Guaranty Bancorp's Form 8-K filed on July 19, 2017.
|
REXR | Hot Stocks16:14 EDT Rexford Industrial launches $150M "At the Market" stock offering - Rexford Industrial launched a new "At the Market" stock offering program with total capacity of $150M, having utilized the previous $125M ATM program. Under both programs, the company issued an aggregate of 4,398,476 shares of common stock during the quarter ended June 30. The shares were issued at a weighted average offering price of $26.52 per share, providing gross proceeds of approximately $116.6M and net proceeds of approximately $114.9M. The new program has approximately $145.2M of remaining capacity.
|
QCOM | Hot Stocks16:14 EDT Qualcomm: 'Delivered better than expected results in our semiconductor business' - "We delivered better than expected results in our semiconductor business this quarter, which drove EPS above the midpoint of our expectations versus our April updated guidance," said Steve Mollenkopf, CEO of Qualcomm Incorporated. "Our products and technologies continue to enable the global smartphone industry, and we are expanding into many exciting new product categories, including automotive, mobile computing, networking and IoT. We believe that we hold the high ground with regard to the dispute with Apple, and we have initiated new actions to protect the well-established value of our technologies."
|
TMUS | Hot Stocks16:14 EDT T-Mobile trading to resume at 4:35 pm ET - T-Mobile shares are expected to resume trading at 4:35 pm ET, with quotation expected to resume at 4:30 pm ET, according to Nasdaq.
|
HURN | Hot Stocks16:13 EDT Van Berkom & Associates reports 5.15% passive stake in Huron
|
REXR | Hot Stocks16:13 EDT Rexford Industrial acquires industrial park for $210.5M - Rexford Industrial acquired a six-building industrial park for approximately $210.5M. The acquisition was funded with the company's line of credit as well as the issuance of a $125M note. The company acquired Rancho Pacifica Industrial Park, consisting of six buildings totaling approximately 1.17 million square feet on 56.01 acres, for $210.5M, or approximately $180 per square foot.
|
AA | Hot Stocks16:12 EDT Alcoa narrows FY17 adjusted EBITDA view to $2.1B-$2.2B from $2.1B-$2.3B - For 2017, Alcoa continues to project relatively balanced global markets for bauxite and alumina with a modest surplus for aluminum. In global alumina, Alcoa now projects the market to range from being in balance to a slight deficit of 800 thousand metric tons in 2017, an improvement from the range of balanced to slight surplus expected in the first quarter of 2017. In global aluminum, the company maintains its expectation for a modest global surplus between 300 thousand to 700 thousand metric tons. Alcoa has increased its 2017 forecast for global aluminum demand growth to a range of 4.75 to 5.25 percent, up from 4.5 to 5 percent in the first quarter of 2017.
|
SRT | Hot Stocks16:12 EDT StarTek announces partnership with TriageLogic - STARTEK announced a partnership with URAC accredited TriageLogic to expand its medical triage solutions and provider medical support services. The partnership allows STARTEK to provide healthcare clients with an enhanced solution to evaluate and treat patients utilizing 24/7 medical triage based on the gold standard Schmitt-Thompson protocols by registered nurses. TriageLogic's secure, hosted solution is a repository for nursing protocols, physician/practice profiles and encounter documentation. The HIPAA-compliant software also provides clinics and hospitals with access to live patient logs and real-time patient updates with minimal integration.
|
PBCT | Hot Stocks16:11 EDT People's United acquires LEAF Commercial Capital - People's United Bank, N.A. announced today that it has entered into an agreement to acquire LEAF Commercial Capital, Inc. Based in Philadelphia, PA, LEAF is one of the largest, independent commercial equipment finance companies in the U.S., with approximately $500 million of annual originations. Under the terms of the agreement, People's United will acquire approximately $730 million of net investment in leases and loans and retain approximately $250 million of securitizations. Remaining LEAF borrowings are expected to be repaid at close and the acquisition will be immediately accretive to People's United earnings. The transaction is expected to close during the third quarter of 2017.
|
TMUS | Hot Stocks16:10 EDT T-Mobile CEO says Q2 results 'proof consumers are responding' - "We just delivered a quarter with record service revenue, record-low churn, strong net income and record Adjusted EBITDA - all while leading the industry in postpaid phone growth. On top of that, our network just keeps getting better and faster while the Duopoly's networks seem to be choking after we forced them to go unlimited. Make no mistake about it, the Un-carrier will not stop forcing change in this industry and our Q2 results are more proof that consumers are responding," said John Legere, President and CEO of T-Mobile.
|
AXP | Hot Stocks16:10 EDT American Express reports Q2 adjusted Card Member spending up 8% - "There were many signposts of progress this quarter: adjusted revenue growth accelerated to 8%; adjusted Card Member spending was up 8% and spread across business units and geographies; healthy loan growth and credit quality; strong new card acquisition - particularly among affluent consumers in the U.S.; and continued progress on reducing operating expenses," said CEO Chenault. "The work is not complete, but we're now moving forward with a stronger foundation and a blueprint for growth in the years ahead."
|
CHRW | Hot Stocks16:10 EDT CH Robinson Worldwide trading halted, news pending
|
QCOM | Hot Stocks16:09 EDT Qualcomm says returned $1.1B to shareholders in Q3 - "During the third quarter of fiscal 2017, we returned $1.1 billion to stockholders, including $844 million, or $0.57 per share, of cash dividends paid and $300 million through repurchases of 5.2 million shares of common stock. On July 13, 2017, we announced a cash dividend of $0.57 per share payable on September 20, 2017 to stockholders of record as of the close of business on August 30, 2017."
|
TMUS | Hot Stocks16:09 EDT T-Mobile raises FY17 branded postpaid net customer additions view to 3M-3.6M - Branded postpaid net customer additions guidance for FY17 is increasing to 3M-3.6M from 2.8M-3.5M. "Net income is not available on a forward-looking basis," the company stated. T-Mobile raised adjusted EBITDA target to between $10.5B-$10.9B, up from the prior guidance range of $10.4B-$10.8B. Adjusted EBITDA target includes expected leasing revenues of $0.85B-$0.95B, increased from the prior guidance range of $0.8B-$0.9B. Cash purchases of property and equipment, excluding capitalized interest, guidance is unchanged at $4.8B-$5.1B, but the company said it expects to be at the high end of the guidance range.
|
ALIM | Hot Stocks16:09 EDT Alimera Sciences allowed to reduce enrollment in Iluvien study - Alimera Sciences announced that the United Kingdom's Medicines and Healthcare Products Regulatory Agency has given final approval to reduce the size of its Iluvien Registry Safety Study. A post-marketing study, IRISS was originally designed to follow 800 Iluvien patients over five years. However, consistently positive real-world safety data from IRISS and other post-marketing studies led Alimera to seek a smaller sample size. Alimera enrolled the 550th patient in January of this year, making the anticipated last patient, last visit date January 2020.
|
AXP | Hot Stocks16:09 EDT American Express reports Q2 Global Commercial Serv. net income $500M, down 13% - Global Merchant Services reported second-quarter net income of $430 million, up 15 percent from $373 million a year ago. Corporate and Other reported second-quarter net loss of $239 million compared with net loss of $229 million a year ago.
|
KMI | Hot Stocks16:09 EDT Kinder Morgan announces future dividend increases and share buyback program - Kinder Morgan announced that its board of directors approved a cash dividend of 12.5c per share for the quarter payable on August 15 to common shareholders of record as of the close of business on July 31. Additionally, as result of substantial balance sheet improvement achieved since the end of 2015, KMI is announcing multiple steps to return significant value to shareholders. First, KMI announced it expects to declare an annual dividend of 80c per share for 2018, a 60% increase from the expected 2017 dividend. The first 2018 increase is expected to be the Q1 2018 dividend. Additionally, the company plans to increase its dividend to $1.00 per share in 2019 and $1.25 per share in 2020, a growth rate of 25% annually. Finally, the board authorized a $2B share buyback program, which represents approximately 5M of KMI's current market capitalization. KMI expects to declare dividends of 50c per share for 2017 and use cash in excess of dividend payments to fully fund growth investments and further strengthen its balance sheet.
|
AXP | Hot Stocks16:08 EDT American Express reports Q2 U.S. Consumer Serv. net income $440M, down 59% - U.S. Consumer Services reported second-quarter net income of $440 million, down 59 percent from $1.1 billion a year ago. The year-ago period included Costco-related revenues, expenses and a portion of the previously mentioned portfolio sale gain. International Consumer and Network Services reported second-quarter net income of $209 million, down 8 percent from $228 million a year ago. Total revenues net of interest expense were $1.4 billion, up 1 percent from a year ago. The increase primarily reflected higher discount revenue, net interest income and net card fees, partially offset by the benefit of a contractual partner payment in the prior year.
|
QCOM | Hot Stocks16:06 EDT Qualcomm reports Q3 MSM chip shipments 187M
|
BG | Hot Stocks16:06 EDT Bunge launches program to reduce costs by $250M in late 2019 - Bunge announced a comprehensive global Competitiveness Program to improve its cost position and deliver increased value to shareholders. The program aims to reduce overhead costs by approximately $250M once fully implemented. These savings are in addition to the savings generated through the company's existing industrial productivity program. The company will additionally be reducing its 2018 total capex spend from a previously announced $750M to $650M. The company expects the Competitiveness Program to provide modest benefits to 2017 earnings. Approximately $100M of the savings are anticipated to be realized in 2018 and $180M in 2019. Full run rate cost savings of $250M are expected to be achieved by the end of 2019. The company expects total non-recurring charges associated with the program to be 0.8-1.2x of targeted savings, most of which are expected to be cash charges spread over the next two and half years. The company expects Q2 adjusted EPS to be modestly profitable, but below the low end of the range of analyst estimates, primarily driven by challenging global Agribusiness market conditions.
|
QCOM | Hot Stocks16:05 EDT Qualcomm sees Q4 MSM chip shipments 205M-225M
|
FVE | Hot Stocks16:03 EDT Five Star Senior Living's Rehab and Wellness unit announces expansion initiative - Five Star Senior Living announced that the company is expanding its rehabilitation and wellness services to senior living communities outside of its current operations. Along with this expansion initiative, Five Star's Rehab & Wellness division is rebranding with a new name: Ageility Physical Therapy Solutions and a new logo. Five Star Senior Living will expand its rehabilitation services outside of its communities by establishing partnerships with other senior living providers. This expansion is a result of Five Star's commitment to meeting the growing need for rehabilitation services and the changing needs and wants of the seniors that Five Star serves.
|
AERI | Hot Stocks16:02 EDT Aerie Pharmaceuticals reports 'positive' Roclatan Phase 3 safety results - Aerie Pharmaceuticals reported the successful 12-month safety results of the company's "Mercury 1" Phase 3 registration trial for its fixed-dose combination product candidate, Roclatan(TM). Mercury 1 is a 12-month safety and efficacy trial which included a 90-day efficacy endpoint. As previously reported, both Mercury 1 and Mercury 2, the company's second Phase 3 registration trial of Roclatan, achieved their 90-day primary efficacy endpoints of demonstrating statistical superiority over each of its components at all measured time points, including Aerie product candidate Rhopressa 0.02%, and market-leading prostaglandin analogue latanoprost, all of which were dosed once daily in the evening. "With these positive 12-month Mercury 1 data, we have again demonstrated the consistent and well-understood performance of Roclatan(TM) and Rhopressa(TM) from both a safety and efficacy perspective. Roclatan(TM) has the potential to become the most efficacious IOP-lowering therapy to enter the market, if approved, bolstered by an overall favorable safety and tolerability profile. We continue to expect to submit our Roclatan NDA in the first half of 2018," said Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer at Aerie.
|
TMUS | Hot Stocks16:01 EDT T Mobile trading halted, news pending
|
CPB | Hot Stocks15:43 EDT Campbell Soup hires Shakeel Farooque to head e-commerce unit in North America - The company highlighted it's plans to accelerate the company's digital and e-commerce capabilities by forming an e-commerce unit in North America. Campbell has a goal of generating $300M in e-commerce sales over the next five years. Alexander said, "We're investing in digital and e-commerce across the enterprise with a goal of building industry-leading capabilities and relationships that will drive innovation in this space." To support these efforts, the company announced it has hired Shakeel Farooque as Vice President and Head of Digital and E-Commerce to lead the unit. Farooque's background is in retail, where he leveraged data to understand consumer behaviors and build omni-channel capabilities for Kohl's, eBay and Amazon, Inc. The company also outlined its plans to partner with leading e-commerce companies, such as the recently announced $10M investment and strategic partnership with online meal kit company Chef'd, and steps it is taking to create a more flexible distribution system to serve e-commerce channels.
|
CPB | Hot Stocks15:38 EDT Campbell Soup looks to add sales by broadening snack business - Campbell anticipates adding approximately $20M in sales across its three divisions over the next five years by broadening its snacking business beyond cookies and baked snacks to include soup, mini meals and fresh snacks, with a focus on mindful kids snacking.
|
BAC | Hot Stocks15:37 EDT Bank of America notes issues with client access to online/mobile banking - Bank of America's verified news account on Twitter stated that "some clients may have been unable to access some of our online/mobile banking apps; however many clients are now operating normally." Reference Link
|
CPB | Hot Stocks15:37 EDT Campbell Soup targets adding $200M in sales across three units in next 5 years
|
CPB | Hot Stocks15:35 EDT Campbell Soup targets $300M in e-commerce sales over the next five years - Campbell's plans to accelerate the company's digital and e-commerce capabilities by forming an e-commerce unit in North America. Campbell has a goal of generating $300 million in e-commerce sales over the next five years.
|
CMG | Hot Stocks15:30 EDT Hedge fund manage Bill Ackman tweets photo of himself ordering at Chipotle - Ackman tweeted, "Eating our own cooking @ ChipotleTweets and making my own mix at savorwavs.com." In September of 2016, Ackman reported a 9.9% stake in Chipotle. In the filing at the time, Pershing said it intended to engage in discussions with Chipotle's board and management. Pershing said at the time that the stock is undervalued and attractive. Shares of Chipotle are lower by .05% in late day trading as advances are made in broader market indices, after the fast-casual restaurant company's latest food scare. Reference Link
|
LPI | Hot Stocks15:14 EDT Laredo Petroleum up 12% to $12.40 after reopening for trading
|
LPI | Hot Stocks15:13 EDT Laredo Petroleum trading resumes
|
MA | Hot Stocks15:09 EDT MasterCard expands choice in retail payments with more QR programs - MasterCard outlined plans for greater choice in retail payments through the planned expansion of its QR-based programs. Beginning this month, the company will broaden its solutions to offer QR codes that can be scanned by either consumers or merchants under a common set of global specifications. Mastercard has worked with EMVCo and other industry players to create a new global QR standard. These standards ensure consistency in QR codes both generated and captured on a consumer's mobile phone. "Today's news builds on the momentum of our QR work in India and Africa," said Ajay Bhalla, president of global enterprise risk and security, Mastercard. "We look forward to the adoption of the EMVCo global QR standards. In the meantime, we'll continue to work with our customers and partners to make every device a secure way to pay and be paid." The use of QR codes in certain markets complements the extensive investment in contactless payments to provide merchants of all sizes - from international chains to individual shop owners and street vendors - a fast, secure and inexpensive way to accept payments. Launched in 2016, Masterpass QR already provides people with any type of mobile phone the ability to safely make in-person purchases without a plastic card. A consumer scans a QR code displayed at the merchant's checkout on their smartphone or by entering a text code into their feature phone. The company's consumer-presented solution will allow the merchant to scan a QR code from a smartphone and process the payment through the Mastercard network. It will leverage M/Chip technology to provide a secure way to pay based on EMV infrastructure.
|
LPI | Hot Stocks15:01 EDT Laredo Petroleum confirms process to sell interest in Medallion Pipeline - Laredo Petroleum confirmed that Medallion Gathering & Processing, the sole owner of the Medallion - Midland Basin pipeline system, has initiated a process to potentially sell 100% of the ownership interests in MGP. Laredo's wholly-owned subsidiary Laredo Midstream Services, owns 49% of the ownership interests in MGP. "At this time there can be no assurance that such potential sale will ultimately be consummated or, if consummated, the specific terms of such sale. Laredo anticipates that it will have no further comments on this potential transaction until such time as a deal is consummated, if applicable," Laredo stated.
|
PSXP | Hot Stocks14:54 EDT Phillips 66 Partners increases quarterly distribution 5% to to 61.5c per unit - Phillips 66 Partners announces that the board of directors of its general partner declared a second-quarter cash distribution of 61.5c per common unit. This quarter's distribution represents an increase of 5% over the previous quarterly distribution of 58.6c per unit and a 22% increase over second-quarter 2016.
|
LPI | Hot Stocks14:51 EDT Laredo Petroleum trading halted, news pending
|
GWW... | Hot Stocks14:40 EDT Industrial suppliers fall after Grainger results, continued impact from Amazon - Shares of industrial supply stocks are falling after peer Grainger (GWW) reported financial results Wednesday morning. Second quarter results topped analyst expectations on the bottom line, with Q2 earnings per share of $2.74 besting expectations of $2.65. However, revenue for the quarter was a bit shy of analyst expectations. The company noted that the 7% point increase in volumes for Q2 revenue was offset by declines of 3% points in price, 1% point from foreign exchange and 1% point from the timing of the Easter holiday. Company operating earnings of $232M for Q2 declined 24% versus $306M in the 2016 quarter. With its quarterly earnings report, the company notified investors that CFO Ron Jadin will be retiring at year-end. The search for Jadin's replacement is underway. 2017 GUIDANCE: Grainger backed its previously issued FY17 outlook with EPS projected to be $10.00-$11.30 on revenue growth of 1%-4% with pricing being down 5-6 points. Grainger sees gross margin down "more significantly in the third and fourth quarter over the prior years," even more than it declined in the first half of the year, "so it's worsening, but we haven't given guidance on that per se." IMPACT OF RESTRUCTURING: CEO Donald MacPherson started the call by calling attention to the impact of restructuring that's going on in the company. "We began winding down the Colombia business in the quarter, which resulted in restructuring charges of $42M. This business has struggled with sustaining profitability, and we are moving quickly to ensure we have businesses with competitive advantage and strong returns in the portfolio," said MacPherson. Grainger is also "taking steps" to restructure its Canadian business. Speaking of its Canadian business the CEO said, "To be clear, we are in the midst of a substantial transformation in the business. This business has scale and should be quite profitable. We are still on track to exit 2017 in a breakeven runway." The company is moving from an unfavorable customer mix in its domestic business to a more favorable mix "over time," said MacPherson, adding that the company is in the midst of renegotiating large customer contracts. Sales in larger customers declining less dramatically but they are still down year-over-year. The company blames the lack of momentum in the quarter to U.S government sales, "in fact, government's 100% of the slowdown," said the CEO responding to an analyst's inquiry. "We saw state and local government holding funds. We saw federal government holding funds in many cases. There are rumors that, that is easing up, but we'll have to wait and see if that plays out. So it is been all government during the quarter." As far as pricing the company sees July "similar to what we've seen thus far this year." as for the rest of the year the company sees pricing to be down "roughly" 6%. AMAZON EFFECT: In an article from April 18, after Grainger's first quarter results, Bloomberg noted that the parts distributor is the latest victim of Amazon (AMZN). In 2012, Amazon launched AmazonSupply.com aimed at at business, scientific and commercial customers and offers products like abrasives & finishing, cutting tools, fasteners, fleet & vehicle maintenance, hydraulics, pneumatics and plumbing, janitorial & sanitation, lab and scientific, materials, occupational health and safety, office, power and hand tools for sale. Recently, another industrial parts distributor Fastenal (FAST) was mentioned as a possible Amazon acquisition target. On July 12, Baird analyst David Manthey said Fastenal is a likely target, because it owns the last mile. PRICE ACTION: Shares of Grainger are off its session low of $160.29, down 7%, to $162.24. OTHERS: Shares of other industrial suppliers are also lower including Fastenal, MSC Industrial Direct (MSM), and WESCO International (WCC).
|
SNI... | Hot Stocks14:40 EDT Scripps, Discovery deal odds debated as reported talks boost media space - Shares of Scripps Networks (SNI) and Discovery Communications (DISCA) are on the rise following reports from both The Wall Street Journal and Reuters that the media companies are in talks to merge. While research firm Citi sees a deal as likely, Credit Suisse analyst Omar Sheikh believes the Journal's initial report has "low credibility." MERGER TALKS: Yesterday, The Wall Street Journal said that Discovery Communications is in discussions to merge with Scripps Networks. A similar report from Reuters added that Viacom (VIAB) also had held talks to buy Scripps. CREDIT SWISS QUESTIONS DEAL CHANCES: Commenting on the news, Credit Suisse's Sheikh told investors that he believes the Journal's report "looks vague," and his initial view is that it has "low credibility." Combining the two portfolios of unscripted cable networks has some industrial logic, but previously reported discussions between the companies probably came to nothing because the price and structure of a transaction could not be agreed upon, the analyst contended, adding that he struggles to see what might have changed now. Sheikh reiterated an Underperform rating and a $24 price target on Discovery's shares. BULLISH ON DEAL: Citi analyst Jason Bazinet, on the other hand, told investors that he views the reports as "credible" and finds it likely that Discovery and Scripps Networks reach an agreement. Furthermore, Bazinet argued that the pressures on the traditional cable network ecosystem are acute enough and valuations are low enough that he can see merits to this potential combination. Assuming a 20% premium is offered to Scripps, a deal would likely be about 10% accretive to Discovery, Bazinet noted, citing his M&A math. Meanwhile, JPMorgan analyst Alexia Quadrani said she sees both a strategic and financial rationale for a merger between Scripps Networks and Discovery Communications, pointing out that a combined company would have greater leverage with domestic distributors and advertisers. Discovery could also help Scripps with its international rollout, Quadrani contended, adding that there is potential for cost and tax synergies. However, she believes that with no terms mentioned in any of the press reports on the deal talks, it is difficult to evaluate any potential transaction. Further, the analyst noted that the speculation "may end up just being chatter" coming out of last week's media executive conference in Sun Valley. Nonetheless, Quadrani believes the press reports should have a "very positive influence" on media stocks, which she noted have been out of favor. The analyst expects to see particular outperformance from heavily shorted media names such as AMC Networks (AMCX). PRICE ACTION: In afternoon trading, shares of Scripps Networks have jumped almost 15% to $76.87, while Discovery Communications' stock has gained 4% to $27.09 and AMC Networks is up 4% to $59.25. Other media names, including 21st Century Fox (FOXA), Viacom and Disney (DIS), are also higher in afternoon trading.
|
SNI... | Hot Stocks14:40 EDT Scripps, Discover deal odds debated as reported talks boost media space - Shares of Scripps Networks (SNI) and Discovery Communications (DISCA) are on the rise following reports from both The Wall Street Journal and Reuters that the media companies are in talks to merge. While research firm Citi sees a deal as likely, Credit Suisse analyst Omar Sheikh believes the Journal's initial report has "low credibility." MERGER TALKS: Yesterday, The Wall Street Journal said that Discovery Communications is in discussions to merge with Scripps Networks. A similar report from Reuters added that Viacom (VIAB) also had held talks to buy Scripps. CREDIT SWISS QUESTIONS DEAL CHANCES: Commenting on the news, Credit Suisse's Sheikh told investors that he believes the Journal's report "looks vague," and his initial view is that it has "low credibility." Combining the two portfolios of unscripted cable networks has some industrial logic, but previously reported discussions between the companies probably came to nothing because the price and structure of a transaction could not be agreed upon, the analyst contended, adding that he struggles to see what might have changed now. Sheikh reiterated an Underperform rating and a $24 price target on Discovery's shares. BULLISH ON DEAL: Citi analyst Jason Bazinet, on the other hand, told investors that he views the reports as "credible" and finds it likely that Discovery and Scripps Networks reach an agreement. Furthermore, Bazinet argued that the pressures on the traditional cable network ecosystem are acute enough and valuations are low enough that he can see merits to this potential combination. Assuming a 20% premium is offered to Scripps, a deal would likely be about 10% accretive to Discovery, Bazinet noted, citing his M&A math. Meanwhile, JPMorgan analyst Alexia Quadrani said she sees both a strategic and financial rationale for a merger between Scripps Networks and Discovery Communications, pointing out that a combined company would have greater leverage with domestic distributors and advertisers. Discovery could also help Scripps with its international rollout, Quadrani contended, adding that there is potential for cost and tax synergies. However, she believes that with no terms mentioned in any of the press reports on the deal talks, it is difficult to evaluate any potential transaction. Further, the analyst noted that the speculation "may end up just being chatter" coming out of last week's media executive conference in Sun Valley. Nonetheless, Quadrani believes the press reports should have a "very positive influence" on media stocks, which she noted have been out of favor. The analyst expects to see particular outperformance from heavily shorted media names such as AMC Networks (AMCX). PRICE ACTION: In afternoon trading, shares of Scripps Networks have jumped almost 15% to $76.87, while Discovery Communications' stock has gained 4% to $27.09 and AMC Networks is up 4% to $59.25. Other media names, including 21st Century Fox (FOXA), Viacom and Disney (DIS), are also higher in afternoon trading.
|
WMT | Hot Stocks14:34 EDT Wal-Mart opens new e-commerce fulfillment center in Davenport, FL - Florida Governor Rick Scott, Walmart officials and community leaders attended the grand opening of Walmart's new e-commerce fulfillment center in Davenport, Fla., Tuesday. The facility is estimated to bring more than 1,500 jobs to Polk County. The new facility will house millions of items dedicated to fulfilling online orders and will enable faster shipping directly to customers or to stores for free pickup. It is the latest addition to the next-generation fulfillment network Walmart is building to support its e-commerce business.
|
S | Hot Stocks13:41 EDT Sprint to add 300 jobs in Central and Northern Florida - Claudio Hidalgo, Sprint's region president for Florida, Puerto Rico and U.S. Virgin Islands, announced more than 300 jobs will be added in Orlando, Tampa-St. Petersburg, Jacksonville and Gainesville as a part of Sprint's national retail expansion strategy. The available jobs will include a combination of retail, business sales, marketing and operations. Most roles will staff the 18 stores Sprint plans to open in the Orlando metro area, 15 new stores in Tampa-St. Petersburg, and 3 stores in Jacksonville and Gainesville this year.
|
JOE | Hot Stocks13:39 EDT Saint Joe Co. transaction with Fairholme Funds granted FTC early termination - A transaction between Fairholme Funds and Saint Joe Co. was granted early termination of the FTC review period, according to a post to the commission's website. Reference Link
|
GTIM | Hot Stocks13:38 EDT Good Times Restaurants announces resignation of Jim Zielke as CFO - Good Times Restaurants announced the resignation of Jim Zielke as CFO and the hiring of Ryan Zink as its new CFO. Zielke's resignation as CFO will take effect on July 31, 2017; however, Zielke will continue as an employee of the company through August 31, 2017 to facilitate his successor's transition into the role. Zielke submitted his formal resignation as a result of an ownership opportunity in a privately held restaurant company. The company has had prior discussions with Zink, who worked extensively with Zielke while at F&H Acquisition Corp, and they will have approximately one month of working together for a transition prior to Zielke's departure. Prior to his appointment as CFO, Zink was the Corporate Finance Director and Reporting Leader, and previously Operations Controller for INVISTA.
|
FOX... | Hot Stocks13:12 EDT Hulu, 20th Century Fox sign deal for 3,000 episodes of dramas, comedies, series - Hulu and 20th Century Fox Television Distribution (FOXA) announced an expansive agreement that will add nearly 3,000 episodes of hit comedies, popular dramas and iconic series to Hulu. In addition to granting streaming rights to every episode of long-running hits including How I Met Your Mother, Burn Notice, Bones and Glee, the deal will also make Hulu the streaming home to all 11 seasons of M*A*S*H and the full NYPD Blue library. Through the agreement, Hulu's offering will expand over the coming weeks with all episodes of popular series from 20th Century Fox including the following titles and many more: How I Met Your Mother, Raising Hope, The Bernie Mac Show, Better Off Ted, Reba, Life in Pieces; NYPD Blue, Bones, Glee, Burn Notice, White Collar, The Practice; M*A*S*H, The Mary Tyler Moore Show, St. Elsewhere, Hill Street Blues, The Bob Newhart Show. The deal follows the announcement of an expanded agreement between Hulu and 20th Century Fox Television Distribution that adds top animated comedies from the studio to Hulu, including Emmy-winning comedy Bob's Burgers, as well as hit series American Dad!, Futurama, and The Cleveland Show. Hulu is a joint venture owned by 21st Century Fox, Comcast (CMCSA), Disney (DIS) and Time Warner (TWX).
|
CPB | Hot Stocks13:04 EDT Campbell Soup says expanding digital capabilities for late stage differentiation - Says expanding digital capabilities for late stage differentiation. Says has returned $3B to shareholders over the past five years.
|
AAPL | Hot Stocks12:56 EDT Apple patents way to call 911 with fingerprint without assailant knowing - On Tuesday, the United States Patent and Trademark Office published a patent by Apple for a method to execute a command in an electronic device through a fingerprint. The patent abstract is as follows:" A device has a touch processing module that processes touch screen input to determine if the manner in which the input was entered indicates that the user intends for execution of a particular command. In one embodiment, the module may acquire fingerprint data from the user's input and analyze the data to determine if the input was entered with a particular finger or finger sequence. In another embodiment, the module may also acquire timing data from the user's entry of a plurality of inputs and analyze the timing data to determine if the touch screen input was entered with a particular timing or cadence. In still another embodiment, the module may also acquire force data from the user's entry of a plurality of touch screen inputs and analyze the force data to determine to determine if the touch screen input was entered with a particular force." In other words Apple has invented a process for an individual to call 911 emergency secretly using your fingerprint.Thus, in a situation where the device owner is forced to unlock or otherwise use his phone by an assailant, contacting emergency services in the conventional manner may not be practical. Accordingly, in conventional systems, a user is unable to comply with an assailant's commands, while at the same time discreetly contacting emergency services." For example, the user may program the electronic device to recognize input entered with her pinky finger as a command to place a "911" call or otherwise contact emergency services. In another example, the user may program the electronic device to recognize input entered with a particular sequence of fingers, such as pinky-ring-pinky, as a command to make an emergency call. Thus, regardless of what routine command the user is ostensibly entering, if the user enters the routine command with the predetermined finger or finger sequence, the user is also entering the predetermined command. For example, a user may be ostensibly be unlocking her device, but by doing so with her predetermined "911 finger" she is also calling the police." Reference Link
|
CPB | Hot Stocks12:56 EDT Campbell Soup CFO: Company making 'good progress' on gross margin expansion - Sees additional opportunities in supply chain, operating model, and acquisition synergies. Says making "good progress" on making gross margin expansion.
|
CPB | Hot Stocks12:52 EDT Campbell Soup sees 'strong' Q4 EPS growth in Global Biscuits and Snacks unit - Campbell Soup CFO Anthony DiSilvestro sees "strong" Q4 earnings growth in Global Biscuits and Snacks division. Says each division has "powerful" brand equities. Says "very pleased" with progress of cost savings program. Shares of Campbell Soup are up 3.06% to $52.56 in early afternoon trading.
|
CPB | Hot Stocks12:45 EDT Campbell Soup sees broadening snacks unit with focus on Mindful Kids Snacking - Says expects to broaden snacks business to include healthier snacks and with a focus on Mindful Kids Snacking. Sees adding $200M in sales across three divisions over the next five years. Says food companies that cannot envision roles in health and well being will not fare well.
|
SAJA | Hot Stocks12:40 EDT Sajan announces holder approval of acquisition by AMPLEXOR International - Sajan announced the shareholder approval and closing of the previously announced acquisition of Sajan by a wholly-owned subsidiary of AMPLEXOR International. Under the terms of the agreement, Sajan shareholders are entitled to receive $5.83 in cash for each share of Sajan common stock they hold. With the completion of the transaction, shares of Sajan common stock will no longer be listed on Nasdaq and trading in Sajan shares has been suspended. Sajan is now a privately held company and a wholly-owned subsidiary of AMPLEXOR.
|
CPB | Hot Stocks12:37 EDT Campbell Soup says nearly $1B of annual net sales from fresh products - Says undertaking "thoughtful" examination of portfolio from real food perspective, will remove any product not consistent with company's real food philosophy. Says nearly $1B of annual net sales from fresh products. Says organic portfolio in Top 10 in the industry. Says Pacific Foods acquisition consistent with health and well being goal.
|
WFC | Hot Stocks12:34 EDT Wells Fargo to pilot digital 'control tower' experience for customers - Wells Fargo & Company announced a new digital banking experience to help solve customers' fragmented financial lives. The new experience, "Control Tower," will provide customers a single view of their 'digital financial footprint' -- including places their Wells Fargo card or account information is connected -- and will enable customers to control when and where their Wells Fargo account is shared via an on/off function from one single, convenient, and secure place. "Control Tower" will go in pilot with Wells Fargo team members later this year and will launch for customers in 2018.
|
CPB | Hot Stocks12:34 EDT Campbell Soup says investing $50M in real food in core business - Says decided to withdraw from the Grocery Manufacturers Association by the end of the 2017 calendar year, says not a business decision. Says increasing transparency on food products through online portals. Says investing $50M in real food in core business.
|
TREE | Hot Stocks12:32 EDT LendingTree promotes Sam Mischner to Chief Sales Officer and Head of Mortgage - LendingTree announced that Sam Mischner has been promoted to Chief Sales Officer and Head of Mortgage. Previously, Mischner served as SVP, Sales and GM, Mortgage. In the newly-formed role of Chief Sales Officer and Head of Mortgage, Mischner will lead the company's sales strategy and operations. Additionally, he will continue to be responsible for LendingTree's home lending product marketplace which includes refinance, purchase, home equity and reverse, while growing LendingTree's vast network of lenders through new client and lender sales.
|
CPB | Hot Stocks12:25 EDT Campbell CEO: Goal to be leading health and well-being company - Campbell Soup president and CEO Denise Morrison says companies and brands must differentiate themselves in "harsh" food products environment in order to survive. Says "real and healthier food" better for consumers and business. Says goal is to be the leading health and well-being company. Says real food has become "non-negotiable" demand from consumers. Comments taken from Campbell Soup's Investor Day.
|
GS | Hot Stocks12:13 EDT Dick Bove says Goldman Sachs is an 'insular' company - Says company showing no improvement over a 10 year period for certain financial metrics. Dick Bove is speaking on CNBC.
|
IMUC | Hot Stocks12:11 EDT Empery Asset Management reports 9.99% passive stake in ImmunoCellular
|
GS | Hot Stocks12:10 EDT Bank analyst Dick Bove says something wrong with Goldman culture - Dick Bove, VP of equity research at Rafferty Capital Markets, says Goldman needs to "shake-up management."
|
MORN | Hot Stocks12:06 EDT Morningstar reports June U.S. mutual fund, ETF asset flows - Morningstar reported estimated U.S. mutual fund and exchange-traded fund asset flows for June 2017. In June, investors put $9.3B into U.S. equity passive funds, down from $13.1B in May 2017. On the active front, investors pulled $14.6B out of U.S. equity funds, compared with $16.2B in the previous month. Morningstar estimates net flow for mutual funds by computing the change in assets not explained by the performance of the fund and net flow for ETFs by computing the change in shares outstanding.
|
GWW | Hot Stocks11:50 EDT Grainger says company still on track to end FY17 with breakeven run rate - Grainger CEO DG Macpherson said, "Looking at 2019, our long-term margin guidance is unchanged." Comments provided during Q2 earnings conference call.
|
IBM | Hot Stocks11:38 EDT IBM opens four new IBM Cloud data centers in London, San Jose, Sydney - IBM announced that four new IBM Cloud data centers are now open, including two in London, England; one in San Jose, California; and one in Sydney, Australia. The four new facilities bring IBM's global cloud data center footprint to nearly 60 across 19 countries and bolster its existing cloud footprint in these regions. IBM is investing to expand its cloud footprint so clients around the world can take advantage of a cloud that is tuned for cognitive and big data workloads while offering flexibility to store data however and wherever they choose. Additionally, IBM is continuing to invest in growing its cloud data center presence to provide businesses with access to cloud infrastructure that is cognitive at the core and designed to be data-first. The additional facilities in London, Sydney and San Jose will help enterprises take advantage of more than 150 APIs and services to deploy next generation applications, ranging from cognitive and blockchain to big data and IoT. Clients such as Bitly and Halliburton are already benefiting from IBM's global network of cloud data centers.
|
CMG... | Hot Stocks11:28 EDT Battleground: Telsey breaks from pack with Chipotle upgrade amid norovirus scare - Shares of Chipotle Mexican Grill (CMG) are in the red for the second consecutive day, following media reports saying the company shut down one of its restaurants after customers claimed they got sick after eating there recently. While this sparked a number of downgrades and cautious commentary by several Wall Street analysts, Telsey Advisory analyst Bob Derrington upgraded Chipotle to Outperform as he sees the pullback in the shares as a buying opportunity. VIRGINIA STORE CLOSURE: Chipotle has shut down a location in Sterling, Virginia, after eight reports were made to the website iwaspoisoned.com claiming that customers fell sick after eating there from July 14-15, according to Business Insider. The company's executive director of food safety, Jim Marsden, told the publication: "We are working with health authorities to understand what the cause may be and to resolve the situation as quickly as possible. The reported symptoms are consistent with norovirus. Norovirus does not come from our food supply, and it is safe to eat at Chipotle." BUY CHIPOTLE: In a research note to investors this morning, Telsey's Derrington upgraded Chipotle to Outperform, with a $440 price target, saying the pullback in the shares, combined with management's more aggressive menu innovation plan, provides a buying opportunity. While the analyst trimmed his 2017 revenue and earnings per share estimates and acknowledged that yesterday's news about the norovirus incident is likely to remind consumers of the risk of dining out, he raised his 2018 estimates after visiting the company's new Chipotle NEXT Kitchen test store and sampling several products in test. These product tests heighten his confidence that management intends to be considerably more proactive in menu innovation to bring more compelling reasons for consumers to visit and return more frequently, Derrington contended. MOVING TO THE SIDELINES: More bearish after the news, BMO Capital analyst Andrew Strelzik downgraded Chipotle to Market Perform and lowered his price target on the shares to $350 from $550. While the analyst pointed out that norovirus at a single location is "not overly significant" on the surface, he believes there is greater uncertainty now as there is a "reasonable probability" that media coverage will outweigh the severity of the incident and create renewed same-store sales weakness. Additionally, Strelzik said his previous survey work suggested that Chipotle's traffic losses accrued to grocery, other Mexican restaurants, and to a lesser extent to other restaurants. Darden's (DRI), McDonalds (MCD), and Panera may have realized traffic benefits in 2016 as a result of the company's traffic losses, he added. His peer at Wells Fargo also downgraded Chipotle to Market Perform and cut his price target on the shares to $375 from $470. The reputational hit facing the company with another food safety scare could slow same-store sales and the earnings recovery progress, analyst Jeff Farmer told investors in a research note of his own. Only 16 months removed from Chipotle's last food scare, the analyst believes consumer response to Tuesday's norovirus headlines could be amplified with Chipotle still building back food safety credibility with many consumers. PRICE ACTION: In late morning trading, shares of Chipotle are fractionally down to about $372 after the stock fell a bit over 4% yesterday.
|
UAL JPM | Hot Stocks11:20 EDT United says wants to strengthen credit card agreement with Chase
|
NTRP | Hot Stocks11:19 EDT Neurotrope: 20ug dose of Brystatin-1 shows evidence of cognition improvement - Neurotrope presented clinical results from its recently completed Phase 2 trial demonstrating that moderate-to-severe Alzheimer's disease patients treated with 20 microg bryostatin-1 showed preliminary evidence of sustained improvement in cognition compared to placebo. The data and comprehensive statistical analysis were presented in the Developing Topics: Clinical Trials oral session, "Effect of Bryostatin-1 on Cognition and Daily Living Tasks in Moderate to Severe Alzheimer's disease Preliminary Report of a Phase 2 Study" at the Alzheimer's Association International Conference 2017 in London. The 13-week, randomized, double-blind, placebo-controlled study evaluated the safety, tolerability and efficacy of bryostatin-1 in 147 moderate-to-severe AD patients across three treatment arms. This is the first placebo-controlled, AD trial of a protein kinase C epsilon activator, which in preclinical studies induced the growth of new synapses and prevented neuronal death. This represents a new therapeutic strategy for AD that directly addresses the emerging consensus that synaptic loss has a major impact on cognitive deficits of AD. The improvements in the primary cognitive endpoint, the Severe Impairment Battery, were observed in the study's 20 microg treatment arm as early as week five, and were maintained throughout the 13-week study. The scores for the secondary functional endpoint, the ADCS-ADL-SIV for the 20 microg treatment arm showed improvement at week 13. Unlike the 20 microg dose, there was no therapeutic signal observed with the 40 microg dose. This contrast between the signal observed with the 20 microg dose versus the 40 microg dose was reinforced by the results of a Cohen's D analysis, part of an in-depth statistical evaluation of the study data that found a consistent signal of benefit in SIB and ADCS-ADL-SIV for the 20 microg dose at the end of the trial.
|
UAL | Hot Stocks11:17 EDT United says hopes to have news on potential Avianca partnership soon - Says not planning to make changes to order book that would impact 2018 CapEx before the end of the year. Commenting on the possibility of transatlantic 737 Max flying, United says "it's something we're going to look at for the medium- and long-term." Says may order 737 Max 8s "one day." Says will take delivery of 12 new 737 Max 9 models in 2019. Says flexible flying program pilot likely to launch in next few weeks. Says hopes to have news on potential Avianca partnership soon.
|
ADTN | Hot Stocks11:14 EDT ADTRAN sees European business down in Q3
|
HIL | Hot Stocks11:10 EDT Hill Int'l selected by GSA as construction manager for Harrisburg courthouse - Hill International said that it has received a contract from the U.S. General Services Administration, Mid-Atlantic Region in Philadelphia, PA to provide construction management services during the construction of a new U.S. Courthouse in Harrisburg, Pennsylvania. The five-year contract has an estimated value to Hill of approximately $6M.
|
RAI BTI | Hot Stocks11:10 EDT RAI investors approve proposals in connection with proposed acquisition by BAT - Reynolds American (RAI) announced that at the company's special meeting of shareholders today, RAI shareholders approved three proposals related to British American Tobacco p.l.c.'s (BTI) proposed acquisition of RAI. RAI shareholders approved:the Agreement and Plan of Merger, including the plan of merger, pursuant to which RAI will become an indirect, wholly owned subsidiary of BAT; this includes the approval of the merger agreement by holders of the outstanding shares of RAI common stock voting at the special meeting that are not owned by the BAT Group or any of RAI's subsidiaries; on a non-binding, advisory basis, the compensation payments that will or may be paid by RAI or BAT to RAI's named executive officers and that are based on or otherwise relate to the proposed transaction and the agreements and understandings pursuant to which such compensation may be paid or become payable; and the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the merger agreement. Approval of the merger agreement by the shareholders of RAI is a condition to the obligations of RAI and BAT to complete the merger. Subject to the satisfaction or waiver of the remaining conditions set out in the merger agreement, the transaction is expected to close on or about July 25.
|
VRTX... | Hot Stocks10:55 EDT Vertex jumps after 'wowing' analysts with cystic fibrosis data - Shares of Vertex (VRTX) are on the rise after the company reported positive data from Phase 1 and Phase 2 studies of three different triple combination regimens in people with cystic fibrosis who have one F508del mutation and one minimal function mutation. Reacting to the news, several Wall Street analysts upgraded the stock to buy-equivalent ratings and raised their price targets on the shares. BUY VERTEX: In a research note to investors this morning, Janney Capital analyst Debjit Chattopadhyay upgraded Vertex to Buy, stating that the Phase 2 data for its three triple combination programs in CF were "significantly above the most optimistic expectations." The analyst argued that the quality of the data should allow Vertex to potentially accelerate commercialization under the "New FDA" and importantly sets the bar very high for competition. Citing its "potential dominance of CF," Chattopadhyay said he thinks Vertex becomes the "most logical large-cap M&A target." Chattopadhyay was not the only analyst upgrading the stock this morning. His peer at Cowen also upgraded Vertex to Outperform, saying efficacy data from its triple regimens showed "breakthrough-quality" results, and will very likely "dramatically" improve the quality of life and extend the life span of 80% of the 75K patients with CF worldwide. Phil Nadeau pointed out that he expects a launch in 2021 and $10B in franchise sales in 2025. The analyst raised his price target on the shares to $200 as he sees a 10-year path of revenue growth for Vertex. Meanwhile, Barclays analyst Geoff Meacham told investors that he thought the Phase 2 data in CF was an "unequivocal success and constitutes a major de-risking event." Citing more confidence in the viability of the triple combo and the likely accelerated development path, the analyst upgraded Vertex to Overweight and raised his price target on the stock to $180. Also this morning, Raymond James analyst Laura Chico upgraded Vertex to Outperform, with a $181 price target, citing the "compelling" efficacy data for its triple-combo CF regimens. WOW: JPMorgan analyst Cory Kasimov began his research note with "Wow. Just wow," following last night's data release from Vertex. To say that the initial results for Vertex's triple combinations beat expectations would be an understatement, Kasimov told investors, adding that the data not only sets up well to reach a large majority of the CF patient population, but also greatly increases the competitive hurdle while also enhancing the scarcity value of the company. He raised his price target on the shares to $175 and reiterated an Overweight rating on the name. Credit Suisse, Stifel, Citi and Piper Jaffray also raised their price targets on the stock following the data release. OTHERS TO WATCH: Competitor Galapagos (GLPG) is sliding in morning trading following Vertex's CF data announcement. However, commenting on the news, H.C. Wainwright analyst Andrew Fein said the data may also be "encouraging" in a roundabout way for Galapagos and another smaller company exploring an add-on to a CF doublet combo, Proteostasis (PTI). If increasing the dosing of the Vertex compounds does not differentiate them further in efficacy, then this consistency in benefit "may truly be a class phenomenon," and similar results should be expected from any competitor add-on agent out there, he suggested. PRICE ACTION: In morning trading, shares of Vertex have gained about 22% to $161.26, while Galapagos and Proteostasis have dropped over 4% and 3%, respectively.
|
ADTN | Hot Stocks10:52 EDT ADTRAN see more monentum in Q4 vs. Q3
|
UAL EADSY | Hot Stocks10:49 EDT United says not providing further updates today on Airbus A350 order
|
UAL | Hot Stocks10:48 EDT United Continental sees domestic PRASM 'about flat' in Q3 - CEO Oscar Munoz says has achieved about 85% reduction on involuntary denied boardings since new policies were implemented over the past few months. Sees domestic PRASM "about flat" in Q3, flat Atlantic PRASM. Says Pacific remains company's most challenging region, hopes reduction in industry capacity growth will help future PRASM growth; Latin PRASM a "bright spot." Expects Q3 capacity growth to be biased toward higher domestic. Says "sad" to retire 747 fleet but says will help 2H profitability. President Scott Kirby says will invest $200M-$300M more than previously forecast in IT, facilities, other areas of business. Says acquisition of used forecast "difficult to forecast," will continue to be important part of strategy. Says 2017 to be high point of CapEx, will head lower in 2018. Comments taken from the Q2 earnings conference call. United Continental is down 4% to $75.74 in morning trading.
|
FSLR... | Hot Stocks10:43 EDT Axiom says buy First Solar as U.S. industry boosted by possible trade action - The shares of a number of solar companies are rising after research firm Axiom wrote that the sector is benefiting from increased U.S. demand ahead of a price floor that could be imposed by the U.S. towards the end of the year. Axiom upgraded its rating on First Solar (FSLR) to Buy from Hold and raised its rating on Chinese solar company JA Solar (JASO) to Hold from Sell. THESIS: Bankrupt solar company Suniva has petitioned the U.S. government to impose a minimum price of 78c per watt on all imported solar panels sold in the U.S., versus last quarter's price of 35c per watt, noted Axiom analyst Gordon Johnson II. President Trump is expected to decide the issue at the end of this year, although his decision could be delayed until January 2018, Johnson stated. In anticipation of the possible price increase and shipment delays that the price floor could cause, solar power project builders are buying large amounts of solar modules now, according to Johnson. As a result, module producers' Q2 results will probably beat expectations and their Q3 results could surpass expectations by a "material amount," he stated. Although Johnson has a "positive near-term bias" toward solar companies, he kept a Market Underweight rating on the sector. FIRST SOLAR: Johnson increased his 2017 shipment estimate for the company to 2.7 GW from 2.2 GW and raised his 2018 shipment estimate for the company to 3.1 GW from 2.9 GW. He noted that the company would be exempt from the price floor. Citing increases in the company's average sales prices, he raised his 2017 EPS estimate to $1.21 from 31c. Analysts' consensus estimate is 56c. Johnson raised his 2018 EPS estimate for the company to 80c from 55c. Analysts' consensus estimate is 69c. He increased his price target on the shares to $51 from $43. JA SOLAR: The company's Q3 EPS will come in at 21c, versus the consensus estimate of a (6c) per share loss, Johnson predicted. Johnson estimated that the company's module business is worth $7 per share and increased his price target on the name to $7 from $3, but added that the standing $9.69 per share take private offer from its CEO caps the stock's upside. CANADIAN SOLAR: The China-based company will benefit from selling solar assets at a profit as well as from temporarily higher module prices, wrote Johnson, who kept an $18 price target and a Buy rating on the shares. JINKOSOLAR: The company's Q2 EPS and Q3 EPS will beat expectations by a significant amount, driven by higher U.S. module prices, Johnson believes. The analyst, who says that the company's module business is worth $28 per share, keeps a Hold rating on Jinko shares. LOSE/LOSE FOR CHINESE COMPANIES: Johnson believes that Chinese solar companies will face a lose/lose scenario after Trump decides the price floor issue. If the floor is approved, demand for Chinese modules in the U.S. will drop significantly, causing global prices to decline, he stated. If it's not approved, demand will return to normal levels, causing prices here to drop significantly, Johnson believes. PRICE ACTION: In morning trading, First Solar climbed 4.5%, JA Solar rose 3%, Canadian Solar gained 3% and JinkoSolar surged 8%.
|
ADTN | Hot Stocks10:41 EDT ADTRAN had two 10% of revenue customers in Q2
|
ADTN | Hot Stocks10:41 EDT ADTRAN Q2 international revenue up 31% YoY
|
ADTN | Hot Stocks10:40 EDT ADTRAN Q2 domestic revenue up 10% YoY - Comments are from Q2 earnings conference call.
|
WILC | Hot Stocks10:31 EDT G. Willi-Food says Pavel Buber 'released' from position as CFO - G. Willi-Food International announced that Pavel Buber has been released from his position as CFO. Yitschak Barabi, the former controller has been appointed as interim CFO.
|
FULT | Hot Stocks10:29 EDT Fulton Financial sees FY17 NII at high-end of prior guidance range - Fulton Financial's prior FY17 NII guidance was mid-to-high single-digit growth. The company sees annual average growth rate in the mid-to high-single digits in Loans & Deposits. Sees Asset Quality provision driven primarily by loan growth. Sees Non-interest income, excluding securities gains, of mid-to high-single digit growth rate. Sees low-to mid-single digit growth rate for FY17 non-interest expense. In net interest margin, the company expects modest improvement in Q2 (2 to 7 basis points; quarterly improvement of 3 to 9 basis points during Q3 and Q4, with variability within that range based on further changes in the federal funds rate and competitive pressure on deposit pricing. Guidance provided during Q2 earnings conference call and slides presented during the call.
|
XCO | Hot Stocks10:18 EDT EXCO Resources halted for volatility after jumping 56c to $2.18
|
AIR BA | Hot Stocks10:15 EDT AAR Corp. signs agreement with flydubai to support Boeing 737 MAX aircraft - AAR (AIR) has expanded its relationship with flydubai by signing a long-term contract to provide comprehensive flight-hour component support for its new Boeing (BA) 737 MAX aircraft. The Dubai-based airline is set to take delivery of 100 Boeing 737 MAX 8 aircraft ordered at the 2013 Dubai International Airshow by the end of 2023. This is AAR's first agreement to support the new aircraft and will utilize the company's extensive global supply chain network, including its new parts warehouse in Dubai.
|
PM | Hot Stocks10:08 EDT Philip Morris general counsel testifies at U.S. commission hearing - Marc Firestone, Senior Vice President and General Counsel of Philip Morris International, appeared as an invited witness before the Commission on Security and Cooperation to offer expert testimony in support of the Commission's objective of addressing the security and economic threats posed by the illicit trade in tobacco. The hearing was held on Capitol Hill in Washington, D.C. "PMI has a clear business imperative to combat the problem of the illegal tobacco trade and ensure our products are legally sold in the market for which they are intended," Firestone stated. He highlighted that the global illicit tobacco trade annually deprives governments of 40-50 billion USD in lost tax revenue, a figure greater than that of the illicit trade in oil, wildlife, timber, arts and antiquities, and conflict minerals combined. Mr. Firestone noted that "criminals are the only promoters of the global illegal tobacco trade." "The revenues that governments and law abiding manufacturers like PMI lose every year to the illicit trade in tobacco are huge," Firestone told Commission members. "However, the threat posed to safety, security, and the rule of law in Europe, the United States and around the globe is where the interests of our company and the concerns of this Commission most pointedly intersect."
|
UTX | Hot Stocks10:04 EDT Carrier:Continues to honor commitment to employ 1,100 associates in Indianapolis
|
UTX | Hot Stocks10:03 EDT Carrier says approx. 300 employees to leave this week as part of prior plan - Carrier continues to honor its 2016 commitment to employ approximately 1,100 associates in Indianapolis. As announced in November, this includes headquarters and engineering jobs and more than 800 employees supporting our world-class gas furnace manufacturing center. This week, approximately 300 employees will leave Carrier as part of the previously announced plan to relocate fan coil manufacturing production lines. These team members include more than 30 associates who have chosen to take advantage of the company's Employee Scholar Program and pursue degree programs. In addition to reimbursing four-year education costs, Carrier will also reimburse technical training costs for those who prefer to pursue a vocational technical certification program. All team members will also receive a one-time payment, severance pay and six months of medical insurance continuation beyond separation. As previously announced, in total, this transition will impact approximately 600 Indianapolis jobs over the next several months. The impacted employees will have an opportunity for employment across UTC's manufacturing operations. United Technologies, parent company to Carrier, announced in June that over the next three years it expects to hire nearly 25,000 people in the U.S., of which more than 5,000 new positions will be created in support of the company's innovative new products.
|
UTX | Hot Stocks10:02 EDT Carrier says approximatey 300 employees to leave this week as part of prior plan - Carrier continues to honor its 2016 commitment to employ approximately 1,100 associates in Indianapolis. As announced in November, this includes headquarters and engineering jobs and more than 800 employees supporting our world-class gas furnace manufacturing center. This week, approximately 300 employees will leave Carrier as part of the previously announced plan to relocate fan coil manufacturing production lines. These team members include more than 30 associates who have chosen to take advantage of the company's Employee Scholar Program and pursue degree programs. In addition to reimbursing four-year education costs, Carrier will also reimburse technical training costs for those who prefer to pursue a vocational technical certification program. All team members will also receive a one-time payment, severance pay and six months of medical insurance continuation beyond separation. As previously announced, in total, this transition will impact approximately 600 Indianapolis jobs over the next several months. The impacted employees will have an opportunity for employment across UTC's manufacturing operations. United Technologies, parent company to Carrier, announced in June that over the next three years it expects to hire nearly 25,000 people in the U.S., of which more than 5,000 new positions will be created in support of the company's innovative new products.
|
LMT | Hot Stocks10:01 EDT Lockheed Martin awarded $37.7M contract from U.S. Air Force - Lockheed Martin received an Undefinitized Contracting Action for $37.7M from the U.S. Air Force for continued development of a new wing design for the Joint Air-to-Surface Standoff Missile - Extended Range. The new wing design will add greater range to the cruise missile, which currently has a range of more than 500 nautical miles. Analysis on an enhanced wing design began in March 2016.
|
FTR | Hot Stocks10:01 EDT Frontier Communications expands partnership with Vivial - Frontier Communication has expanded its partnership with Vivial, a martech company that offers a full range of customer engagement tools, to resell its Marketing Platform in many of Frontier's markets throughout the country.
|
NEM | Hot Stocks10:00 EDT Newmont Mining raises dividend to 7.5c from 5c per share - Newmont Mining announced earlier that its board declared a quarterly dividend of 7.5c per share of common stock, payable on September 28 to holders of record at the close of business on September 14. The dividend of 7.5c per share is triple the dividend paid in the prior year quarter and up from the 5c paid to stockholders in June of this year.
|
SRPT | Hot Stocks09:45 EDT Sarepta, Clinigen launch MAP for eteplirsen to treat DMD patients - Clinigen Group plc's Idis Managed Access division and Sarepta Therapeutics have initiated a Managed Access Program, or MAP, for eteplirsen in certain geographies to treat Duchenne Muscular Dystrophy patients amenable to exon 51 skipping. This MAP provides a mechanism through which physicians can legally and ethically prescribe eteplirsen to patients who meet pre-specified medical criteria and where funding can be secured. Initially, the program is being launched in select countries within Europe, North America and South America for certain patients where eteplirsen is not currently approved. Sarepta plans to expand the program to include more countries over time. The program will be administered by Clinigen Group plc's Idis Managed Access division.
|
USB | Hot Stocks09:34 EDT U.S. Bancorp sees positive operating leverage in Q3, Q4
|
IMNP | Hot Stocks09:33 EDT Immune Pharmaceuticals says continuing plan to spin off Cytovia - Immune Pharmaceuticals confirmed it is continuing to structure and pursue a spin-off of Cytovia, its subsidiary dedicated to the development and commercialization of Oncology drugs and drug candidates, into a separate, stand-alone publicly-traded company. It is contemplated that a pro rata distribution of shares in Cytovia would be issued to Immune shareholders as a dividend. The spin-off is expected to create two independent publicly-traded companies with distinct strategic plans, leadership, growth strategies, and operational and development priorities. The new Cytovia, will focus on the development and commercialization of novel immuno-oncology and hematology therapeutics to meaningfully improve cancer patients' lives. Cytovia aims to grow into a global specialty biopharmaceuticals company through potential acquisitions and rejuvenation of late-stage development or commercial-stage products. The initial core asset of Cytovia will be CEPLENE an immunotherapy treatment approved in Europe in combination with low-dose IL2 for remission maintenance in patients with Acute Myeloid Leukemia. on June 15, 2017, Immune signed, on behalf of its subsidiary Cytovia, a definitive asset purchase agreement with Mylan to acquire the rights to Ceplene in the territories that Immune did not previously own; namely Asia, Europe, Middle East and Africa. The European Marketing Authorization allows us to commercialize in 30 EU countries and serves as the basis for approval in Latin America, Russia and other Eastern European countries and countries in the Middle East, Africa and Asia. The addressable market for remission maintenance of Acute Myeloid Leukemia patients that could be treated with Celine exceeds 10,000 patients in Europe, Russia and other Eastern European countries. The current reimbursement in Europe is $25,000 for a full course of treatment. On July 11, 2017, Cytovia entered into a definitive licensing and commercialization agreement with Pint Pharma Int'l Ltd. for all the markets in Latin America. Pint will implement Early Market Access programs until full registration in those countries. The addressable Latin American market for Ceplene is estimated at 4,000 patients. Under the Pint agreement, Cytovia is eligible to receive 35% of net sales in Latin America subject to the terms contained therein. Additionally, Pint has committed to make a $4 million equity investment in Cytovia. Cytovia is committed to further development of Ceplene in additional indications such as Myelo-Displasic Syndrome, also known as CMML for which a pilot clinical study has been initiated in Sweden. Cytovia expects that it will be well-positioned to establish itself as a "pure play" commercial stage specialty pharmaceutical company in the highly attractive immuno-oncology field, with an integrated pipeline portfolio.
|
IMNP | Hot Stocks09:33 EDT Immune Pharmaceuticals continuing plan to spin off Cytovia
|
AVID HLIT | Hot Stocks09:29 EDT Avid patent infringement claim against Harmonic set to proceed to trial - Avid (AVID) addressed the status of patent infringement litigation which has been ongoing against Harmonic (HLIT) since 2011. Although Avid has not considered this litigation material for purposes of its disclosures, Harmonic Inc. has previously included information about the litigation in its public filings. Following the latest rulings by the U.S. Court of Appeals for the Federal Circuit in Washington, D.C. and the United States Patent and Trademark Office, or USPTO, Avid will be planning to proceed to trial against Harmonic. Since October 2011, Avid has brought two patent infringement lawsuits against Harmonic in the United States District Court for the District of Delaware-one involving Harmonic's MediaGrid storage system and Avid's U.S. Patent Nos. 6,760,808 and 7,487,309, and the other involving Harmonic's Spectrum(TM) media server system and Avid's U.S. Patent No. 5,495,29. Harmonic has responded to these suits by seeking to have the USPTO review and nullify Avid's patents through procedures known as reexamination and inter partes review. In 2014, the USPTO rejected Harmonic's challenges to claims 11-16 of Avid's 291 Patent, and Harmonic unsuccessfully appealed that decision to the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., which upheld the claims in 2016. Avid's case of infringement against Harmonic's Spectrum products is scheduled for trial in November 2017. Likewise, after that same court ordered a new trial in the MediaGrid case in 2016, Harmonic sought to have the USPTO cancel the patent claims in Avid's 808 and 309 Patents. On May 12, 2017, the USPTO upheld the claims of Avid's 309 Patent, but found the claims of the 808 Patent unpatentable. Now that the claims of the 309 Patent have been confirmed as patentable, Avid's infringement case against Harmonic and its MediaGrid system is expected to proceed to the new trial ordered by the Federal Circuit. Based on expert testimony, Avid expects its claim against Harmonic could result in up to $35 million in damages through 2013. Avid expects that this amount has increased materially since then. However, the outcome of litigation is inherently uncertain and Avid may not recover any or all of damages it seeks. Additionally, Avid currently plans to appeal the USPTO's decision with respect to the 808 Patent to the Federal Circuit.
|
NTNX VMW | Hot Stocks09:29 EDT Nutanix CEO tells VMware executive to 'shut up and behave' - In reply to a now-deleted tweet that appeared to compare Nutanix (NTNX) to Enron sent by Lee Caswell, the VP of Products, Storage & Availability at VMware (VMW), Nutanix CEO Dheeraj Pandey tweeted late on July 14: "Hey Lee, shut up and behave. Don't denigrate your office at @VMware like this. At @Nutanix, we've been patient with your trolling tweets." Reference Link
|
MDVX | Hot Stocks09:28 EDT Medovex announces first human cases using Its DenerveX device - Medovex announced the first human cases performed using its recently launched DenerveX System and first revenue events. The first human use cases for the DenerveX System took place in Manchester, England and Medovex anticipates performing up to as many as 30 plus additional procedures by the end of August. The company also reached its first revenue events in the EU with others soon to expected to follow. The DenerveX System which has recently received CE Mark approval and clearance for commercialization in the European countries, is a new and novel device designed for enduring relief of Facet Joint Syndrome, also known as spinal osteoarthritis, spinal arthritis, or facet joint osteoarthritis, related to lower back pain. DenerveX system is not yet FDA cleared.
|
MS... | Hot Stocks09:23 EDT On The Fly: Pre-market Movers - UP AFTER EARNINGS: Morgan Stanley (MS), up 3.9%... M&T Bank (MTB), up 2%... Exponent (EXPO), up 11.9%... Grainger (GWW), up 2%... ADTRAN (ADTN), up 5.4%... Textron (TXT), up 1.8%... ASML (ASML), up 3.7%. ALSO HIGHER: Vertex (VRTX), up 26.1% after it reported "positive" data from Phase 1 and Phase 2 studies of three different triple combination regimens in people with cystic fibrosis who have one F508del mutation and one minimal function mutation... Scripps Networks (SNI), up 15.3% after the Wall Street Journal reported that Discovery Communications (DISCA) is in discussions to merge with the company... Discovery Communications is up 6.5%. DOWN AFTER EARNINGS: CSX (CSX), down 2.5%... United Continental (UAL), down 4.4%... IBM (IBM), down 2.5%... Crown Castle (CCI), down 2% after reporting quarterly results, announcing it will acquire Lightower for $7.1B in cash, and filing to sell $3.25B in stock and $1.5B in convertible preferred stock. ALSO LOWER: McCormick (MKC), down 5.2% after announcing it will acquire RB Foods from Reckitt Benckiser (RBGLY) for $4.2B.
|
CSX | Hot Stocks09:22 EDT CSX says expects productivity gains to increase in Q3 vs. Q2
|
USB | Hot Stocks09:21 EDT U.S. Bancorp says would look at bolt on acquisitions in merchant acquiring
|
USB | Hot Stocks09:17 EDT U.S. Bancorp CEO says believes has reached 'inflection point' in expense growth - President and CEO Andy Cecere sees Q3 total loan growth back to 1%-1.5% company views as more normalized. Says credit metrics "excellent." Says efficiency has been at higher end of historical range over last few quarters, believes growth rates of costs will begin to moderate. Expects positive operating leverage in Q3, Q4 on y/y basis, y/y noninterest expense growth to be in line with long term target range of 3%-5%. Cecere commented that USB's balance sheet is "strong," core businesses are "well positioned for an economic and regulatory backdrop that has the promise to be more conducive to growth." Does not expect average cash balances to increase meaningfully from current levels. Sees Q3 net interest margin up in a manner "similar" to last year, or 4-5bps. Expects merchant acquiring revenue to be "essentially flat" in Q3, normalize in Q4. Sees taxable equivalent tax rate 29% in Q3. Says has not yet seen evidence of resurgence in CapEx cycle. Says believes has reached inflection point in expense growth. Comments taken from the Q2 earnings conference call. U.S. Bancorp is up about 1.3% in premarket trading.
|
MS | Hot Stocks09:15 EDT Morgan Stanley CFO says potential for disruption from Mifid 'pretty high' - Morgan Stanley CFO Jon Pruzan said the potential for near-term disruption from the upcoming EU law known as "Mifid II" is "pretty high," but its too early to make a call on the real impact of the regulations.
|
CSX | Hot Stocks09:15 EDT CSX says expects employee count down about 3,000 for full year - Says employee count down about 2,300 so far this year.
|
FRED | Hot Stocks09:12 EDT Fred's Pharmacy appoints Jason Jenne as CFO - Fred's announced the appointment of Jason Jenne as EVP and CFO. Jenne succeeds Rick Hans, who is stepping down from the company to pursue other opportunities. Hans will remain in an advisory capacity until August 18 and will work closely with Jenne to ensure a smooth transition. These changes are effective as of today. Jenne joined Fred's Pharmacy in September 2016 as SVP, finance. In addition to leading financial and risk management across the company, Jenne will be responsible for ensuring that the finance organization enables Fred's Pharmacy to successfully execute its healthcare transformation and capitalize on the significant market opportunities ahead. These responsibilities include oversight of cash flow, SG&A management and capital allocation strategy.
|
EPD ETP | Hot Stocks09:10 EDT Enterprise Products says court rules in favor of appeal against ETP - Enterprise Products Partners (EPD) announced the company has prevailed in its appeal against Energy Transfer Partners (ETP). This appeal stems from a 2014 Dallas jury verdict in a lawsuit filed by Energy Transfer over a proposed pipeline project that was cancelled due to a lack of customer support. "This case has been a long, hard battle and Enterprise is grateful to the Fifth Court of Appeals for their hard work," the company said. In April 2011, Enterprise and Energy Transfer signed a series of agreements disclaiming any partnership or joint venture absent executed definitive documents and board approvals of the two companies. Definitive agreements were never executed and board approval was never obtained. The parties signed these disclaiming agreements precisely to avoid the type of lawsuit brought here. "This case needed decisive action because it had the potential to stand as one of the worst for business in Texas since the Texaco v. Pennzoil decision from the 1980s," said Enterprise appellate lawyer David E. Keltner. "Sophisticated parties need the right to rely on written contracts. Partnership by ambush is a bad public policy and goes against the freedom to contract guaranteed by the Texas Constitution. The business world breathed a sigh of relief today when 'partnership by ambush' was ruled out of bounds in Texas."
|
ICE | Hot Stocks09:05 EDT NYSE says leads global IPO listings for 1H17 - The New York Stock Exchange said it hosted the majority of initial public offerings conducted in the first half of 2017 with 49 new listings, raising over $19.3 billion in capital, representing 88 percent of all proceeds raised in the U.S. In the first six months of 2017, the market for IPOs rebounded from 2016, which was impacted by global equity market volatility.
|
TTEK | Hot Stocks09:04 EDT Tetra Tech selected by USACE for $150M contract - Tetra Tech announced that the company was selected by the U.S. Army Corps of Engineers, Mobile District for a multiple-award contract valued at $150M. Under this five-year, indefinite delivery, indefinite quantity contract, Tetra Tech will provide comprehensive architecture and engineering services to the Army Installation Management Command to support federal agencies throughout the U.S. and its territories. Tetra Tech will assist IMCOM in implementing the BUILDER Sustainment Management System, a web-based software application developed to assist engineers, technicians, and managers make decisions about building infrastructure and maintenance. This innovative platform provides the ability to store building information, detailed system inventories, and key infrastructure attributes such as age, material, and capacity to guide short-term and long-term work plans and investment strategies. Tetra Tech will use BUILDER SMS to support the U.S. Army in presenting objective and defensible facility budget forecasts to Congress.
|
CMG | Hot Stocks09:04 EDT Chipotle, RZA launch Savor.wavs digital experience - Chipotle Mexican Grill said it has collaborated with RZA, multi-platinum hip-hop legend and creator and producer of the Wu-Tang Clan, to create SAVOR.WAVS, a digital experience that reinterprets each ingredient in Chipotle's food as music and responsive visuals.
|
DAL | Hot Stocks09:01 EDT Delta Air Lines to expand in Asia with nonstop Shanghai-Atlanta flight - Delta Air Lines is expanding in Asia with new service between Hartsfield-Jackson Atlanta International Airport and Shanghai Pudong International Airport starting in July 2018. The new Atlanta flight will be Delta's fourth U.S. gateway to Shanghai, complementing existing service from Detroit, Seattle and Los Angeles. The flight will provide convenient one-stop access to more than 150 destinations in the U.S. and Latin America from Shanghai. In addition, the flight will also provide access to more than 50 destinations in China with codeshare partner China Eastern.
|
CSGS CHTR | Hot Stocks09:01 EDT CSG Systems extending relationship with Charter through December 31, 2021 - CSG Systems International (CSGS) announced that it will expand and extend its agreement with Charter Communications (CHTR) through December 31, 2021. CSG's contract extension with Charter streamlines all existing billing and customer care contracts with Time Warner and Bright House into a single Charter contract. Under the new contract, CSG will continue to provide a comprehensive set of customer care and billing solutions. In addition, Charter will deploy CSG Workforce Express for field service management, scheduling, dispatch, automation and mobile technician support.
|
PRGO | Hot Stocks09:00 EDT Perrigo's generic version Of DermOtic oil receives FDA approval - Perrigo has received final approval from the FDA for its AB rated Abbreviated New Drug Application referencing DermOtic Oil, 0.01% Ear Drops. The company anticipates launching this product within 90 days. DermOtic Oil, 0.01% Ear Drops are indicated for the treatment of chronic eczematous external otitis in adults and pediatric patients two years old and older. Annual market sales for DermOtic Oil, 0.01% Ear Drops for the 12 months ending May 2017 were approximately $26M.
|
CSX | Hot Stocks08:57 EDT CSX says has 40% of positive train control miles in service - Says stored locomotives should rise to more than 1,000. Says hump yards to be reduced to around three. Says biggest challenge is cultural change.
|
MS | Hot Stocks08:50 EDT Morgan Stanley CFO says uncertainty, seasonality may weigh on near-term activity
|
GCBC | Hot Stocks08:49 EDT Greene County Bancorp raises annual dividend to 39c per share from 38c per share - Greene County Bancorp announced that its board has approved a quarterly cash dividend of 9.75c per share on the company's common stock. The dividend reflects an annual cash dividend rate of 39c per share which represents a 2.6% increase from the previous annual cash dividend rate of 38c per share. The cash dividend for the quarter ended June 30, will be paid to shareholders of record as of August 15, and is expected to be paid on or about August 31.
|
RYAM OAK | Hot Stocks08:49 EDT Oaktree says Glass Lewis supports vote against Rayonier acquisition of Tembec - Investment funds managed by Oaktree Capital Management (OAK), which own 19.9% of the common stock of Tembec, announced that Glass Lewis recommended that shareholders of Tembec vote against Rayonier's (RYAM) proposed acquisition of Tembec. Glass Lewis analyzed the proposed transaction and the value it provides for Tembec shareholders and concluded that Tembec shareholders should vote against this transaction at the current offer price. In making its recommendation, Glass Lewis noted the following:"We believe Oaktree makes a credible argument that Rayonier could likely justify paying a higher purchase price, including based on comparable market valuations and in light of the significant increase in the market price of Rayonier shares following announcement...We believe there is reasonable cause for concern with the valuation of the proposed transaction, which implies EBITDA multiples that fall well below multiples paid in precedent transactions and below the trading multiples of comparable companies....In the event Rayonier declines to improve its offer terms, we believe the company faces reasonable stand-alone prospects, with improved volume and pricing contracts for 2017 and growing core markets." Oaktree agrees with Glass Lewis's conclusion that Tembec shareholders vote AGAINST the proposed transaction.
|
LLL EADSY | Hot Stocks08:47 EDT L3's MX-15 EO/IR system selected by Airbus Helicopters for foreign militaries - L3 Technologies (LLL) announced that its WESCAM division has received an order from Airbus Helicopters (EADSY) to provide 37 MX-15 electro-optical and infrared imaging systems for installation on multiple fleets of H225M Caracal helicopters. The systems will be installed in France before being delivered to two foreign governments for military deployment. The first delivery of 19 units will support a variety of missions, including search and rescue, aeromedical evacuation and assistance, and disaster relief. The second delivery will provide a highly detailed, multispectral view of combat search and rescue, naval operations, medical evacuation and military transportation efforts to mission operators.
|
LH | Hot Stocks08:46 EDT LabCorp introduces Adamts13 test for blood clot disorder - LabCorp has begun offering its new, proprietary ADAMTS13 test to distinguish diseases characterized by life-threatening, acute thrombotic microangiopathy. TMA is a relatively rare but serious syndrome in which small blood vessels develop blood clots, which result in the mechanical destruction of red blood cells. TMA can result from one or more of several medical conditions and medications. LabCorp's ADAMTS13 test is performed using new liquid chromatography-tandem mass spectrometry technology. It was developed and validated by LabCorp's in-house team of scientists and technical specialists. Other available tests for ADAMTS13 activity are fluorescence-based assays. Compared to those options, LabCorp's ADAMTS13 assay offers significant improvements in sensitivity, in consistency of results when testing is performed over time; and in reduced interference from increased levels of bilirubin, which is a common issue with comparable fluorescence-based assays. Importantly, due to the greater cost-efficiency of the LC-MS/MS technology, LabCorp's test will be performed daily, seven days per week, compared to only three days per week for existing assays. Results for LabCorp's ADAMTS13 test will usually be available the same day if the specimen is received in the laboratory by 10:30 a.m. Eastern time.
|
MS | Hot Stocks08:45 EDT Morgan Stanley CFO 'remains comfortable' with full-year NII guidance
|
URGN AGN | Hot Stocks08:45 EDT UroGen Pharma to receive $7.5M milestone payment from Allergan - UroGen Pharma (URGN) announced that it will receive a milestone payment of $7.5M under its exclusive worldwide licensing agreement with Allergan Pharmaceuticals, or Allergan, a wholly owned subsidiary of Allergan (AGN), resulting from Allergan's submission of an Investigational New Drug application for RTGel in combination with BOTOX for the treatment of overactive bladder to the FDA.
|
CSX | Hot Stocks08:44 EDT CSX says has idled 26,000 rail cars, 900 locomotives - Says expects to ship 30M tons of export coal in 2017. Says crude oil trains have dropped to zero. Comments from Q2 earnings conference call.
|
MS | Hot Stocks08:42 EDT Morgan Stanley CFO remaining 'cautious' on M&A view for rest of year - Morgan Stanley CFO Jon Pruzan said on the bank's Q2 call that M&A volumes remained "healthy" in Q2. However, he called out a decrease in larger transformational deals on a year-to-date basis compared to 2016, citing the current market environment "impacting management's decision to act." Uncertainty over taxes, regulatory reform and the broader political landscape will "likely weigh on activity" and Morgan Stanley remains "cautious as we look towards the rest of the year," said Pruzan.
|
JMU | Hot Stocks08:40 EDT JMU partners with Nippon ACCESS and TANSH in China - JMU's consolidated affiliated entity in China, Shanghai Zhongmin Supply Chain Management Co., Nippon ACCESS and TANSH Global Food Group have reached a three-way partnership agreement on the strategic development of China's food and beverage market and had signed a Letter of Intent on Business Cooperation. Under this collaboration, the company will continue its strategy to build the food catering and hotel B2B2C supply chain platform, and will fully cooperate with ACCESS and TANSH to develop international trade, research and development of food materials and food products, as well as overall supply chain cooperation. Specific cooperation includes food materials and food products international trade cooperation and holistic store supply chain collaboration in foodservice and hotel industry.
|
SRPT | Hot Stocks08:39 EDT Sarepta, Clinigen launch managed access program - Sarepta Therapeutics and Clinigen Group Idis Managed Access division, have initiated a Managed Access Program, or MAP, for eteplirsen in certain geographies to treat eligible Duchenne muscular dystrophy, or DMD, patients amenable to exon 51 skipping. This MAP provides a mechanism through which physicians can legally and ethically prescribe eteplirsen to patients who meet pre-specified medical criteria and where funding can be secured. Initially, the program is being launched in select countries within Europe, North America and South America for certain patients where eteplirsen is not currently approved. Sarepta plans to expand the program to include more countries over time. The program will be administered by Clinigen Group plc's Idis Managed Access division. Clinigen is the trusted global leader in access to unlicensed medicines delivering over 220 MAPs to thousands of patients, helping physicians access medicines when no other treatment options are available.
|
MS | Hot Stocks08:39 EDT Morgan Stanley CEO calls out 'three tailwinds' - Morgan Stanley Chairman and CEO James Gorman, speaking on the company's Q2 earnings call, said that "with the firm now on solid footing, performance could still materially improve in the years ahead," adding that he sees three tailwinds, "each of which has the potential to impact our long-term performance in a material and positive way," worth calling out. On capital, Gorman said that while Morgan Stanley intends to invest in its business, it is determined to use any excess capital to continue to reduce its share count. On tax reform, Gorman said "U.S. corporate taxes are too high" and that a "sensible realignment of tax rates with other major developed economies" would be a "clear positive for our business and corporate America in general." On interest rates, he said each movement in rates, assuming a measured path, should benefit Morgan Stanley's business.
|
AET... | Hot Stocks08:35 EDT Trump says Senators must keep 'promise to America' on healthcare - President Trump just tweeted, "I will be having lunch at the White House today with Republican Senators concerning healthcare. They MUST keep their promise to America!" Publicly traded insurers in the Healthcare space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
|
CNDT | Hot Stocks08:31 EDT Conduent awarded patent for facial expression recognition technology - Conduent has been awarded a U.S. patent for technology that automatically recognizes facial expressions using images from low resolution cameras. Since becoming an independent public company on December 31, 2016, the company has been awarded more than 20 patents, with several related to computer vision technology. The patent, along with the others awarded this year, adds to Conduent's portfolio of more than 300 U.S. Patents and approximately 400 pending U.S. Patent Applications.
|
GIB | Hot Stocks08:31 EDT CGI Group awarded $92.5M in U.S. Army contracts - CGI has been awarded several contracts totalling $92.5M from the U.S. Army to provide varying degrees of support across four separate Aviation and Missile Command programs. Each of the contracts was awarded to CGI as part of a subcontracting team to the incumbent prime contractor and each are five years in length if all option years were to be exercised.
|
ALOT | Hot Stocks08:31 EDT AstroNova's TrojanLabel unit forms distribution alliance with Nilpeter - AstroNova announced that its TrojanLabel ApS business unit and Nilpeter A/S have established an international distribution agreement for the Trojan2 mini digital label press. Under the agreement, the Trojan2 will be marketed and distributed through Nilpeter's subsidiaries in the United States, Brazil, the Asia-Pacific, the United Kingdom and Ireland.
|
UAL | Hot Stocks08:21 EDT United Continental: Involuntary denied boardings down 88% in June - Says Investor Day initiatives "on track." Says involuntary denied boardings down 88% in June. Expects earnings improvement to come from all areas of the business. Says Phase I of revenue management system enhancements coming in Q3. Says "pleased" with results of Basic Economy rollout in mainland U.S. domestic markets. Says summer capacity growth "efficient," "performing well." Expects CapEx to decrease ~$1B in 2018 versus 2017's elevated level. Comments from slides that will be presented on the Q2 earnings conference call. United Continental is down nearly 4% in premarket trading.
|
LTEA | Hot Stocks08:19 EDT Long Island Iced Tea announces distribution partnership for Pacific Islands - Long Island Iced Tea announced a new partnership to distribute its beverages in New Zealand, Polynesia, Micronesia and Melanesia1 through Stellare New Zealand Limited, part of the Stellare Group. New Zealand has an estimated population of 4.5 million people and has a NARTD tea market that has grown at a 3.5% CAGR from 2011 to 2016, and projected to reach $7.4M by 2021.3 Long Island Iced Tea Corp. has been the registered owner of the 'Long Island Brand' trademark in New Zealand since December 12, 2014.
|
ICAD | Hot Stocks08:18 EDT iCAD announces 'positive' study results regarding use of Xoft Axxent eBx System - iCAD announced that results of a matched-pair cohort study of 369 early-stage non-melanoma skin cancer, or NMSC, patients treated with the company'sXoft Axxent Electronic Brachytherapy, or eBx, System or Mohs micrographic surgery showed that rates of recurrence of cancer were virtually identical. Mohs micrographic surgery is accepted as the most effective technique for removing basal cell carcinoma and squamous cell carcinoma, the two most common skin cancers. The study results were published online in the peer-reviewed Journal of Contemporary Brachytherapy. "In recent years, we have seen substantial clinical evidence indicating that electronic brachytherapy offers comparable results to Mohs surgery in appropriately selected early-stage non-melanoma skin cancer patients," said Rakesh Patel, MD, lead investigator of the study, Radiation Oncologist and Medical Director, Department of Radiation Oncology, Good Samaritan Hospital, Los Gatos, CA. "These data provide an entirely new level of clinical research confirming that treatment with eBx can help patients achieve similar low rates of recurrence with excellent cosmetic outcomes compared to Mohs surgery."
|
CSX | Hot Stocks08:17 EDT CSX says Q3 volume outlook 'favorable' - Says key indicators support growth in most markets: U.S. export coal demand remains strong; Consumer sentiment at high levels; Infrastructure project growth continues; Expects truck market fundamentals to gradually improve. Says specific headwinds will impact a few markets: Auto production declining; Crude economics remain challenged; Short-haul domestic coal loss continues. Comments from presentation slides.
|
GOOD | Hot Stocks08:15 EDT Gladstone signs 10-year lease extension at Mt. Pocono, PA property - Gladstone Commercial that it has executed a 10-year lease extension with United Envelope at its 223,275 square foot industrial property in Mt. Pocono, PA. The lease extension will maintain the property's 100% occupancy with United Envelope through July 2031.
|
CLBS | Hot Stocks08:15 EDT Caladrius announces 50% of subjects have been treated in CLBS03 Phase 2 trial - Caladrius Biosciences announces that 50% of subjects have been treated in The Sanford Project: T-Rex Study, a prospective, randomized, placebo-controlled, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of the Company's CLBS03 as a treatment for recent-onset type 1 diabetes. A pre-specified interim analysis of early therapeutic effect will occur after the six-month post-treatment follow-up visit, with results expected to be announced in late 2017 or early 2018. This complete study will enroll a total of approximately 111 subjects age 8 to 17.
|
GSK | Hot Stocks08:14 EDT GSK won't proceed with plans to build biopharmaceutical facility in Ulverston
|
GSK | Hot Stocks08:14 EDT GlaxoSmithKline says to cut approx. 320 permanent jobs over four years - Overall, GSK employs a total of around 17000 people across the UK of which 5000 are in UK manufacturing operations. The proposals announced today for Worthing and Slough will result in a reduction of approximately 320 permanent jobs over the next 4 years.
|
GSK | Hot Stocks08:14 EDT GlaxoSmithKline exploring options to divest smaller noncore nutrition brands
|
ATNX | Hot Stocks08:13 EDT Athenex intiates patient enrollment for Oraxol plus ramucirumab Phase 1b trial - Athenex announced that its global Phase 1b clinical trial of Oraxol plus ramucirumab in gastric cancer has commenced with first patient dosed recently.
|
GSK | Hot Stocks08:13 EDT GlaxoSmithKline says intends to sell Horlicks brand in the U.K. - In its Consumer Healthcare business, the company intends to sell its Horlicks brand in the UK and is proposing to close the associated manufacturing site in Slough where UK product is made. In addition, GSK intends to sell the MaxiNutrition brand in the UK. GSK is also exploring options to divest some other smaller non-core nutrition brands.
|
GSK | Hot Stocks08:13 EDT GlaxoSmithKline to undertake review of cephalosporins antibiotics business - In pharmaceuticals, the company is to undertake a strategic review of its cephalosporins antibiotics business, with an option to sell the business including the associated manufacturing facilities. These medicines are produced at GSK sites in Ulverston, Cumbria, Verona in Italy and part of its Barnard Castle site. The Company has also decided to outsource some manufacturing activity at its Worthing site in the UK. GSK will continue to manufacture other antibiotics such as Augmentin and will continue to conduct research on new antibiotics. The company has also decided not to proceed with a previously planned investment to build a biopharmaceutical facility in Ulverston as it no longer needs the additional capacity.
|
GSK | Hot Stocks08:13 EDT GlaxoSmithKline to invest over GBP140M at certain UK sites through 2020 - GSK set out several announcements made by the company to improve the efficiency and competitiveness of its manufacturing network. These include both investments for respiratory and HIV medicines manufacturing in the UK and strategic reviews, including the sale of several products and a proposal to close a UK manufacturing site. Between now and 2020, the Company plans to invest more than GBP140M at its Ware, Hertfordshire, Barnard Castle, Co Durham and Montrose, Scotland sites. The investments will support expansion of manufacturing for respiratory and HIV medicines. This new investment is in addition to the GBP275M announced last year and investment of over GBP1.2B in UK manufacturing since 2012.
|
KANG | Hot Stocks08:12 EDT iKang Healthcare, China Industrial Asset Management to form investment funds - iKang Healthcare announced that it will cooperate with China Industrial Asset Management, an asset management company with total RMB 185B funds under its management, which is under China Industrial Bank, to form certain healthcare investment funds to invest in medical centers. The aggregate size of the healthcare investment funds will not exceed RMB 502M. An affiliate of Mr. Lee Ligang Zhang, iKang's Chairman and CEO, and an affiliate of China Industrial Asset Management will act as general partners and each contribute RMB 1M to the investment funds. iKang and China Industrial Asset Management will each contribute up to RMB 50M to the investment funds as limited partners. The investment funds will admit other limited partners which will contribute up to RMB 400M.
|
BPTH | Hot Stocks08:10 EDT Bio-Path Holdings receives notice of allowance for U.S. pattent for DNAbilize - Bio-Path Holdings announced that the United States Patent and Trademark Office has issued a notice of allowance for claims related to the Company's proprietary liposomal delivery and antisense technology, DNAbilize, including its use in the treatment of cancers, autoimmune diseases and infectious diseases.
|
NSSC | Hot Stocks08:09 EDT NAPCO Security sees Q4 revenue $25.4M, consensus $24.93M
|
AGN | Hot Stocks08:09 EDT Allergan announces Joseph Boccuzi appointed to board - Allergan announced that Joseph Boccuzi has been appointed to its Board of Directors, effective immediately. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and CEO Practices at Spencer Stuart, following 24 years of service with the global executive search and leadership consulting firm.
|
AXON | Hot Stocks08:07 EDT Axovant Sciences' intepirdine shows potential neuroprotective properties - Axovant Sciences announced new data from a preclinical study which suggests that intepirdine may have neuroprotective properties against vascular injury and neuronal metabolic dysfunction. These results were presented at the 2017 Alzheimer's Association International Conference being held in London July 16 - 20. In the animal model used in this study, intepirdine demonstrated neuroprotective effects under hypoxic and hypoglycemic conditions in an in vitro assay of mixed cortical neuron cultures at clinically relevant concentrations. Specifically, when pre-treated with intepirdine for 24 hours, a decrease in lactate dehydrogenase release, a surrogate marker of cell death, was observed in MCN cultures exposed to oxygen and glucose deprivation. Intepirdine is a 5HT6 receptor antagonist in development for the potential treatment of mild to moderate Alzheimer's disease and Lewy body dementia. Axovant is evaluating intepirdine in MINDSET, a global Phase 3 study in subjects with mild to moderate Alzheimer's disease who are on stable background donepezil therapy, and expects to report topline results from this study in late September.
|
GWW | Hot Stocks08:07 EDT Grainger CEO says Q2 'in line with our expectations' - "The second quarter was in line with our expectations, as we saw continued volume growth from our strategic pricing initiatives in the United States. We remain on schedule to roll out web prices on our entire assortment on Aug. 1," said CEO DG Macpherson. "Outside the United States, we took aggressive action to streamline our portfolio and focus on profitable businesses, as we announced the wind-down of the business in Colombia and previously announced the closing of 59 branches in Canada this year. Based on our confidence from what we are seeing, we are reiterating our guidance for the year," Macpherson concluded.
|
MAGS | Hot Stocks08:06 EDT Magal Security awarded $9.8M in contracts - Magal Security Systems announced that it has recently received a total of $9.8M in orders to provide integrated security solutions and maintenance for three major seaports in the EMEA region. One of the orders is for the Port of Huelva in Spain, the largest in the Spanish Seaport System, involving intrusion detection smart fences and advanced CCTV cameras
|
NTEC | Hot Stocks08:05 EDT Intec Pharma granted patent in Hong Kong for Accordion Pill - Intec Pharma announces that the Patent Registry Intellectual Property Department of Hong Kong has issued a Certificate of Grant of a Hong Kong patent for an Accordion Pill containing certain drugs, including the combination of Carbidopa and Levodopa. The patent, granted under No. HK1158545, is titled "Carbidopa/Levodopa Gastroretentive Drug Delivery" and is currently scheduled to remain in force until April 2029. The patent belongs to the Company's IN-7 patent family, which already includes patents granted in the U.S., Europe, China, Japan, South Korea, South Africa and Israel.
|
HEINY | Hot Stocks08:04 EDT Heineken Americas and U.S. Beverage partnering for import of specialty brands - Heineken Americas Export, appointed U.S. Beverage as the U.S. importer of certain specialty Heineken brands which may include brands from Europe, Latin America, South America, and S.E. Asia. The transition will begin immediately.
|
GWW | Hot Stocks08:03 EDT Grainger announces CFO Ron Jadin to retire at year-end - Ron Jadin, Senior Vice President and CFO announced that he will be retiring at year-end. Jadin joined Grainger in 1998 and has served in various financial roles including as CFO since 2008. The company and the Board of Directors thank Jadin for his many contributions during his tenure. An external search has been launched to identify his successor.
|
RKDA | Hot Stocks08:01 EDT Arcadia Biosciences says FDA accepts EFSE for WUE trait - Arcadia Biosciences announced that the U.S. FDA has accepted an Early Food Safety Evaluation for the company's water use efficiency trait. The EFSE is now applicable to all plant species that feature this trait. The EFSE concluded that the functional protein for the WUE trait, isopentenyl transferase, is safe for humans and animals and would not raise food safety concerns if present in the food supply. This approval is an assurance of safety for WUE crops currently under development and being tested in the field and will expedite the regulatory approvals for this trait. Greenhouse and field trials of the WUE trait have been completed in agronomic crops such as rice, wheat, cotton, peanuts and alfalfa, and Arcadia is currently working with collaborators in rice, potato, sugarcane, cotton and multiple tree species. The African Agricultural Technology Foundation supported the EFSE study through funds from USAID's "Feed the Future" initiative. The data provided in support of the EFSE are consistent with international regulatory requirements for genetically modified crops and will provide Arcadia and its global partners with the basis for future regulatory submittals. Arcadia's WUE trait technology was jointly discovered by researchers at the University of California, Davis and Technion-Israel Institute of Technology. Arcadia holds an exclusive, global license to the technology, with sublicense rights, for use in all crops.
|
MTST | Hot Stocks08:00 EDT MetaStat announces study results of paclitaxel treatment for breast cancer - MetaStat announced results from a study published online on July 5 in Science Translational Medicine authored by MetaStat collaborators from the Albert Einstein College of Medicine and Montefiore Medical Center. This study demonstrated certain types of chemotherapy promote breast cancer tumor cell dissemination and metastasis, including increased circulating tumor cells and TMEM or MetaSite cores, in addition to enhanced expression of pro-metastatic Mena protein isoforms. Consistent with the known requirements for Mena in breast cancer metastasis, paclitaxel-induced dissemination was found to be dependent on Mena protein expression. Previous studies had demonstrated that animals grafted with MMTV-PyMT Mena-null breast cancer tumors fail to develop CTCs or lung metastasis, and paclitaxel-treatment did not promote metastasis of Mena-deficient tumors in the current study. The investigators used the research version of MetaStat's clinically validated and CLIA-approved MetaSite Breast test to quantify changes in the number of MetaSites before and after chemotherapy treatment. In tumor samples from breast cancer patients, neoadjuvant chemotherapy consisting of paclitaxel after doxorubicin plus cyclophosphamide increased MetaSite scores and expression of the pro-metastatic MenaINV isoform. Preclinical studies of patient-derived xenograft and PyMT murine models also demonstrated that chemotherapy increased the density of MetaSites and levels of the MenaINV isoform.
|
NSU | Hot Stocks07:53 EDT Nevsun Resources reports final high grade drill results at Timok Upper Zone - Nevsun Resources reported final assay results from the recently completed infill drilling of the Upper Zone at the company's Timok copper-gold project in Serbia. Drilling confirms continuity and the high-grade nature of the Upper Zone New massive and semi-massive sulphide intersections include: 16.94% Cu and 6.97g/t Au over 25.5m, within 4.46% Cu and 2.38g/t Au over 280.0m; 15.86% Cu and 7.69g/t Au over 27.0m, within 5.18% Cu and 2.28g/t Au over 274.5m; 20.57% Cu and 9.17g/t Au over 49.5m, within 6.77% Cu and 3.67g/t Au over 265.5m; 15.63% Cu and 12.28g/t Au over 19.5m, within 5.37% Cu and 4.94g/t Au over 177.0m. Exploration drilling for additional Upper Zone type deposits is underway. Nevsun CEO Peter Kukielski commented, "The high-grade assays reported today are the final holes from the infill drill program for the Timok Upper Zone. This drilling is enabling development of improved geological and geotechnical models and we expect an upgrade to a high percentage of the resources".
|
WINA | Hot Stocks07:45 EDT Winmark trading resumes
|
IVPAF | Hot Stocks07:39 EDT Ivanhoe Mines names financial institutions to arrange Platreef PGMs financing - Robert Friedland, Executive Chairman of Ivanhoe Mines, and Lars-Eric Johansson, President and CEO, announced that the company has appointed another two mine-financing institutions - KfW IPEX-Bank, a German government owned institution, and the Swedish Export Credit Corporation - as Initial Mandated Lead Arrangers to arrange debt financing for the ongoing development of the company's Platreef platinum-group metals, nickel, copper and gold mine in South Africa. KfW IPEX-Bank and SEK join the initial three IMLAs - Export Development Canada, Nedbank Limited and Societe Generale Corporate & Investment Banking - that were appointed earlier this year. The IMLAs will make best efforts to arrange a total debt financing of up to US$1 billion for the development of Platreef's first-phase, four-million-tonne-per-annum (Mtpa) mine, with preliminary expressions of interest now received for approximately $900M of the targeted $1B financing. The financing will be contingent upon a successful due diligence process including benchmarking the project against the International Financial Corporation's Environmental and Social Performance Standards. Negotiation of a term sheet is ongoing between Ivanhoe's finance team and the IMLAs and discussions were held during the week of July 3rd in Johannesburg, South Africa, and attended by all five IMLAs. This was followed by a site visit to the Platreef Project.
|
AVX | Hot Stocks07:39 EDT AVX to acquire TS&C division of TT Electronics for GBP118.8M - AVX Corporation announced that it has signed a definitive agreement to acquire the Transportation, Sensing & Control division from the UK company, TT Electronics. In accordance with the agreement, AVX will acquire TS&C for a consideration of GBP118.8M, or approximately $155.5M in cash, subject to normal working capital adjustments at closing. The transaction is subject to approval of the TT Electronics shareholders, and other conditions, including regulatory approvals, that are customary for transactions of this type. The TS&C division of TT Electronics designs, develops, manufactures and markets Sensors for temperature, position, and speed, including exhaust/emission control sensors. The company's products are utilized in a broad range of automotive applications.
|
NTRS | Hot Stocks07:35 EDT Northern Trust reports Q2 return on average common equity 11.6% - "Our second quarter results continued to demonstrate our ability to drive strong growth within both our wealth management and institutional businesses. Trust, investment and other servicing fees and net interest income grew 9% and 14%, respectively, compared to the prior year. The growth in fees was driven by strong growth in client assets, as assets under custody/administration and assets under management ended the quarter up 15% and 14%, respectively, compared to a year ago. We remain committed to driving efficiencies in our cost base for the long term, while continuing to invest in people, technology, and regulatory initiatives to support our growing businesses," said Frederick H. Waddell, Chairman and CEO.
|
CPB | Hot Stocks07:34 EDT Campbell Soup reiterates long-term earnings, organic sales targets - Campbell reiterated its long-term targets for organic sales and earnings. The company is targeting long-term organic sales growth of 1 to 3 percent. Excluding currency translation, the company is targeting adjusted EBIT growth of 4 to 6 percent and adjusted EPS growth of 5 to 7 percent. Campbell expects to reach approximately $310 million in annual cost savings by the end of fiscal 2017. The company also continues to expect its current cost savings initiatives to deliver $450 million, or approximately 6 percent of sales, in annual savings by the end of fiscal 2020. This cost savings goal is incremental to the company's ongoing supply chain productivity program. Campbell expects an adjusted gross margin of approximately 38 percent* for fiscal 2017, and expects to generate approximately $1.25 billion in cash flow from operations in fiscal 2017.
|
HLT | Hot Stocks07:33 EDT Hilton urges stockholders to reject TRC Capital's mini-tender offer - Hilton Worldwide Holdings received notice on July 18 of an unsolicited mini-tender offer being conducted by TRC Capital Corporation to purchase up to 2,000,000 shares, or approximately 0.61%, of Hilton's common stock outstanding as of July 17 at a cash price of $59.75 per share. The offering price is approximately 4.4% below the $62.49 closing price per share of Hilton's common stock on July 18. Hilton does not endorse TRC Capital's offer and recommends that stockholders reject the offer because the offer price is below the current market price for Hilton's shares. Hilton urges investors to obtain current market quotations for their shares, consult with their broker or financial advisor and exercise caution with respect to TRC Capital's offer. Hilton recommends that stockholders who have not responded to TRC Capital's offer take no action. Stockholders who have already tendered shares to TRC Capital may be permitted to withdraw those shares in accordance with the mini-tender offering documentation before the expiration of the offer, which is currently scheduled for 12:01 a.m., Eastern Time on Tuesday, August 15. TRC Capital may extend the offering period at its discretion. Hilton is not associated with TRC Capital, its mini-tender offer or any of its mini-tender offer documentation.
|
VRS | Hot Stocks07:32 EDT Verso to close 200,000 tons of annual production capacity at Androscoggin Mill - Verso plans to permanently shut down the No. 3 paper machine and associated equipment at its Androscoggin Mill in Jay, Maine, reducing annual coated paper production capacity at the mill by approximately 200,000 tons. The shutdown will be effective August 1 and is expected to be complete by the end of Q3. The No. 3 paper machine and a recovery boiler and digester that support it were idled in January of this year in response to declining customer demand that resulted in more coated paper capacity than could be filled. Most products made on the No. 3 paper machine were transitioned to lower-cost machines in other Verso mills. The permanent shutdown of the No. 3 paper machine and associated equipment will impact approximately 120 employees at the Androscoggin Mill. Employees affected by the shutdown will receive severance in accordance with Verso's severance policy and Maine state law.
|
XGTI | Hot Stocks07:31 EDT xG Technology's Vislink business receives $1.5M order - xG Technology announced that its Vislink business has received an order valued at approximately $1.5M for microwave communications equipment from a leading medical device manufacturer. The Vislink communications equipment included in the order will form an integral part of an advanced medical device application.
|
GLPG VRTX | Hot Stocks07:25 EDT Galapagos drops 6% to $72.96 following Vertex cystic fibrosis data
|
WINA | Hot Stocks07:19 EDT Winmark commences self-tender offer to purchase up to 400,000 shares - Winmark announced the commencement of a self-tender offer to purchase up to 400,000 shares, or approximately 9.5% of its outstanding common stock, for a price of $124.48 per share. The company intends to finance the tender offer with its existing revolving credit facility as well as an additional term loan. The tender offer will expire at 12:00 Midnight, Eastern Time, on August 16, 2017, unless extended or withdrawn. The Board of Directors determined that it is in the Company's and shareholders' best interest to repurchase shares at this time given the company's financial performance, its access to attractive debt capital, the relatively illiquid trading market for the company's common stock and desire by its largest shareholder to obtain liquidity for a portion of his holdings for estate planning purposes. Winmark has retained Wells Fargo Bank, N.A. as the Depositary for the tender offer and D.F. King & Co., Inc., as the Information Agent.
|
COVS OTEX | Hot Stocks07:15 EDT Covisint shareholder Dialectic Capital issues open letter to shareholders - Covisint (COVS) shareholder Dialectic Capital Management, with beneficial ownership of approximately 7.7% of the company's outstanding shares, issued a public letter to Covisint shareholders announcing its intention to vote against the proposed acquisition of Covisint by Open Text (OTEX) at the company's special meeting of shareholders on July 25. The letter states, among other things: "Plain and simple, we believe the $2.45 per share price that is being offered to Covisint shareholders is completely inadequate. The current offer is seemingly representative of a company in secular decline with no growth opportunities, low margins and no proprietary technology - none of which is the case with Covisint (...) we are troubled by the discounted cash flow analysis generated by Evercore based on management's long term projections. The assumptions in the analysis seem illogical and manufactured to yield the desired outcome of a sale. (...) The current multiple also represents just over 1x recurring revenue, which is unjustifiably low in our view as it is difficult to find any software companies that have sold with that low of a multiple. (...) Further supporting our decision to vote against the proposed acquisition by OpenText is OpenText's own guidance to the street following the announcement of the deal. OpenText indicated that the acquisition of Covisint would be 2% accretive in the upcoming fiscal year ending June 2018. This implies around $13 million of acquired net income for which it is paying $70 million (...) The real tragedy is that after rejecting an offer in the range of $3.00 to $3.75 per share bid last spring and subsequently resisting efforts by shareholders to improve the Company, the Board elected to accept a 27% lower bid at the same time the Company posted a profitable quarter. (...) If the Company were to focus its sales efforts on the auto end market with an emphasis on existing customers, adjust its cost structure to be run profitably and look to grow responsibly either through small acquisitions or internal development, we believe the Company could be sold in the future for a much higher price. (...) To protect the value of our investment and preserve the flexibility to effect a leadership change at the Company, we intend to vote against the proposed acquisition of Covisint by OpenText. (...)"
|
AEMD | Hot Stocks07:14 EDT Aethlon Medical; USPTO grants '333 Patent - Aethlon Medical announced that the United States Patent and Trademark Office has granted U.S. Patent Number 9,707,333 (the '333 Patent), entitled "EXTRACORPOREAL REMOVAL OF MICROVESICULAR PARTICLES." The '333 Patent covers methods of capturing exosomes that include an MHC-I or MHC-II antigen, whereby a patient suspected of receiving a benefit from exosome capture and removal is selected, and the whole blood, plasma, or serum from the patient is contacted with a substrate that includes antibodies specific for an MHC-I or MHC-II antigen. The '333 Patent also covers methods of capturing and removing MHC-I or MHC-II antigen associated exosomes from whole blood, plasma, or serum of a patient, and returning the whole blood, plasma, or serum to the patient with substantially fewer MHC-I or MHC-II antigen associated exosomes. MHC-I and MHC-II antigen associated exosomes contribute to the progression of numerous disease conditions, including cancer, autoimmune disorders and neurodegenerative diseases. The '333 Patent is a continuation of U.S. Patent Number 9,364,601, which covers methods of lectin-based capture of exosomes from a patient, and U.S. Patent Number 8,288,172, which protects the use of the Aethlon Hemopurifier in a method to remove immunosuppressive exosomes from blood. Together, these patents solidify Aethlon's position as a leader in pioneering diagnostic and therapeutic strategies in the field of exosome biology.
|
DNKN | Hot Stocks07:07 EDT Dunkin' Brands appoints Roland Smith to board - Dunkin' Brands appointed Roland C. Smith to its Board of Directors. Smith most recently served as the Chairman and CEO of Office Depot, and earlier in his career was President and CEO of Wendy's and CEO of Arby's Restaurant Group.
|
MS | Hot Stocks07:06 EDT Morgan Stanley CEO says Q2 results 'resilient' in 'subdued trading environment' - James Gorman, Chairman and CEO, said, "Our second quarter results demonstrated the resilience of our franchise in a subdued trading environment. Our wealth management business produced a 25% margin and our strong investment banking results attest to the diversity of our global business. We continue to deliver on our strategic goals and grow shareholder returns."
|
GOOS | Hot Stocks07:05 EDT Canada Goose nominates Maureen Chiquet to board - Canada Goose Holdings announced Maureen Chiquet has been nominated for election to its Board of Directors as an independent director. Most recently, Chiquet was Chanel's first Global CEO.
|
HHS | Hot Stocks07:03 EDT Harte-Hanks announces agreement with Sidus Investment Management - Harte Hanks announced that it has reached an agreement with Sidus Investment Management, LLC, which owns approximately 2.5% of the company's outstanding shares, under which Harte Hanks will appoint Alfred V. Tobia, Jr. and Melvin Keating to its board, effective immediately. As part of the agreement, Harte Hanks has accepted the resignation of current director, Stephen Carley, and the board will increase from seven to eight members. In connection with the appointments, Harte Hanks and Sidus Investment Management have entered into a cooperation agreement. Under the terms of the agreement, Sidus Investment Management has agreed to certain standstill and voting commitments. A copy of the cooperation agreement will be filed with the SEC as an exhibit to a Current Report on Form 8-K to be filed by Harte Hanks.
|
AXTA | Hot Stocks07:02 EDT Axalta Coating makes offer to acquire European, Chinese operations of IVA - Axalta Coating Systems announced that it has made a binding offer to acquire the European and Chinese operations of IVA, one of the world's leading wire enamel manufacturers, from its parent company Superior Essex. IVA, which has been in operation since the late 1930's, develops and produces the latest innovations in wire enamels used to insulate electrical equipment and components. IVA is well known for its broad portfolio of high performance, high quality wire enamels including top coats and self-bonding products. These include state-of-the-art insulating technologies used in the manufacture of e-mobility technology, renewable energy applications, medical equipment, household appliances, and industrial and automotive applications, among others. The transaction includes IVA manufacturing sites in Meyzieu, France and Changzhou, China, which is operated through a joint venture with a local minority partner. The transaction is expected to be completed in late 2017 or early 2018, subject to clearance by applicable regulatory authorities, consultation with IVA's French employee works council and other customary closing conditions. Financial terms were not disclosed.
|
AGR | Hot Stocks07:02 EDT Avangrid affirms FY17 outlook
|
MDGS | Hot Stocks07:02 EDT Medigus enters distribution agreement with Izasa Hospital, S.L.U. in Spain - Medigus announced a distribution agreement in Spain with Izasa Hospital, S.L.U., a distributor of medical products in the hospital sector. The five year commercialization agreement took effect July 1, 2017; Izasa Hospital, S.L.U. will be required to purchase a minimum of EUR 1.4M of Medigus Ultrasonic Surgical Endostapler equipment over the course of the agreement.
|
MS | Hot Stocks07:02 EDT Morgan Stanley reports book value $38.22 as of June 30 - At June 30, book value and tangible book value per common share were $38.22 and $33.24,15 respectively, based on approximately 1.8B shares outstanding.
|
LTBR | Hot Stocks07:01 EDT Lightbridge receives notice of allowance on patent for metallic fuel assembly - Lightbridge announced that it has received a Notice of Allowance from the Korean Intellectual Property Office, or KIPO, for a key divisional patent covering two major inventions: Lightbridge's innovative metallic fuel assembly design for Western-type pressurized water reactors incorporating four-lobe, helically twisted metallic fuel rods, and the company's proprietary manufacturing method for metallic fuel rods using powder metallurgy. The patent is expected to be issued once the registration fee has been paid by Lightbridge.
|
ACRX | Hot Stocks07:01 EDT AcelRx names Raffi Asadorian as CFO, effective August 16 - AcelRx Pharmaceuticals announced the appointment of Raffi Asadorian as CFO, effective August 16. Asadorian brings over 25 years of finance, strategy and corporate development experience to AcelRx, most recently as CFO at Amyris, a commercial-stage biotechnology company.
|
BTX | Hot Stocks07:01 EDT BioTime to present data from Phase I/IIa OpRegen trial at AAO meeting - BioTime announced that an abstract related to the company's retinal tissue implant has been accepted for a paper presentation at the American Academy of Ophthalmology annual meeting being held in New Orleans, Louisiana, November 11-14. The abstract accepted for paper presentation is titled, "Phase 1 and 2a Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Transplanted Subretinally in Advanced Dry-Form AMD Patients." The data will be presented by Dr. Oscar Cuzzani MD PhD, BioTime's Vice President of Clinical Development.The company announced data from the Phase I/IIa clinical trial of OpRegen at the Association for Research in Vision and Ophthalmology annual meeting in May. The presentation reported new clinical trial data with two patients that were treated in cohort 2, where they received a dose of 200,000 cells. Imaging analysis suggests the transplanted OpRegen cells remained in place in an area of the scar that was completely depleted of retinal pigment epithelium because of the advanced stages of the disease. Cell engraftment appears evident in four of the five patients treated thus far. There was also possible evidence of a biological response with some areas appearing to show structural improvement without any signs of retinal edema, a fluid build-up that can further compromise vision. OpRegen is now in a Phase I/IIa dose finding study to evaluate its safety and efficacy in patients who have an advanced stage of the disease, and has received fast track designation by the FDA.
|
GILD | Hot Stocks07:00 EDT Gilead treatment of pediatric Crohn's disease granted FDA orphan status - Gilead Sciences' filgotinib maleate was granted FDA orphan status as a treatment of pediatric Crohn's disease, according to a post to the agency's website. Reference Link
|
MS | Hot Stocks06:59 EDT Morgan Stanley reports Common Equity Tier 1 ratio approximately 16.6% at June 30 - As of June 30, 2017, the Firm's Common Equity Tier 1 and Tier 1 risk-based capital ratios under Advanced Approach transitional provisions were approximately 16.6% and 18.9%, respectively. As of June 30, 2017, the Firm estimates its pro forma fully phased-in Common Equity Tier 1 risk-based capital ratio under the Advanced Approach and pro forma fully phased-in Supplementary Leverage Ratio to be approximately 15.9% and 6.4%, respectively.
|
JNJ | Hot Stocks06:58 EDT Janssen pediatric systemic lupus erythematosus treatment granted orphan status - Janssen Biotech, a Johnson & Johnson company, was granted FDA orphan status for ustekinumab as a treatment of pediatric systemic lupus erythematosus, according to a post to the agency's website. Reference Link
|
MS | Hot Stocks06:58 EDT Morgan Stanley reports Q2 Institutional Securities net revenues $4.8B - Institutional Securities net revenues were $4.8 billion reflecting strength in equity sales and trading and M&A advisory, and improved results in underwriting. Wealth Management net revenues were $4.2 billion and pre-tax margin was 25%.2 Fee-based asset flows for the quarter were $19.9 billion. Investment Management net revenues were $665 million with assets under management of $435 billion.
|
MS | Hot Stocks06:57 EDT Morgan Stanley raises quarterly dividend to 25c per share - Payable on August 15 to common shareholders of record on July 31.
|
MS | Hot Stocks06:57 EDT Morgan Stanley announces $5B share repurchase plan through 2Q18 - During the quarter ended June 30, 2017, the Firm repurchased approximately $500M of its common stock or approximately 12M shares. The Firm announced a share repurchase of up to $5B of common stock beginning in the third quarter of 2017 through the end of the second quarter of 2018.
|
MS | Hot Stocks06:56 EDT Morgan Stanley raises quarterly dividend to 25c per share
|
MS | Hot Stocks06:55 EDT Morgan Stanley announces $5B share repurchase plan through 2Q18
|
WINA | Hot Stocks06:55 EDT Winmark trading halted, news pending
|
SON | Hot Stocks06:52 EDT Sonoco Products names Philippe Guillemot to board - Sonoco has named Philippe Guillemot to its Board of Directors. Guillemot was COO of Alcatel-Lucent SA, Boulogne-Billancourt, France, prior to its acquisition by Nokia Oyj in 2016. Before his tenure with Alcatel-Lucent, Guillemot was CEO and board director of Europcar Group from 2010 to 2012, Guyancourt, France. With his addition to the board, Sonoco has 13 board members. Guillemot is an independent board member and assumes the seat vacated by Ed Lawton, who recently resigned for personal reasons after 17 years on the board.
|
LDOS | Hot Stocks06:50 EDT Leidos awarded $55M prime contract by DOE - Leidos was awarded a prime contract by the Department of Energy, or DOE, Office of Energy Efficiency and Renewable Energy to provide engineering services for an energy and water savings program designed to promote the use of renewable energy technologies. The multiple-award indefinite-delivery/indefinite-quantity contract has a five-year base ordering period, an eighteen month option, and a total contract value of approximately $55M for all awardees. Leidos is one of 21 contractors eligible to compete for task orders under the program.
|
USB | Hot Stocks06:48 EDT U.S. Bancorp reports common equity tier 1 ratio 9.3% at June 30 - At June 30, the estimated common equity tier 1 capital to risk-weighted assets ratio was 9.3% using the Basel III fully implemented standardized approach and was 11.7% using the Basel III fully implemented advanced approaches method.
|
LNN | Hot Stocks06:47 EDT Lindsay increases dividend 3.4% to 30c per share - Lindsay has declared a regular quarterly cash dividend of 30c per share, payable August 31, to shareholders of record on August 17. This quarterly cash dividend rate represents a 3.4% increase in the previous quarterly indicated rate of 29c per share.
|
USB | Hot Stocks06:47 EDT U.S. Bancorp reports Q2 net interest margin 3.04% - Net interest margin of 3.04 percent for the second quarter of 2017 was 2 basis points higher than the second quarter of 2016 and 1 basis point higher than the first quarter of 2017, benefiting from rising interest rates partially offset by increasing average cash balances. Average total loans grew 3.4 percent over the second quarter of 2016 and 0.9 percent on a linked quarter basis. Credit and debit card revenue grew 7.8 percent on a year-over-year basis. Trust and investment management fees increased 6.1 percent on a year-over-year basis Nonperforming assets decreased 19.3 percent on a year-over-year basis and 9.8 percent on a linked quarter basis.
|
USB | Hot Stocks06:46 EDT U.S. Bancorp reports Q2 return on average assets of 1.35% - Reports Q2 average common equity of 13.4%.
|
TXT | Hot Stocks06:32 EDT Textron CEO says Q2 revenues 'primarily driven by the Arctic Cat acquisition' - "Revenues were up in the quarter primarily driven by the Arctic Cat acquisition," said Textron Chairman and CEO Scott Donnelly. "We saw strong performance at Bell and were encouraged by the continued strengthening in commercial helicopter demand."
|
SAIC | Hot Stocks06:32 EDT SAIC awarded $621M U.S. Central Command task order - SAIC has been awarded the U.S. Central Command Command, Control, Communications, and Computers Enterprise Support task order, worth approximately $621M, by the U.S. General Services Administration Federal Systems Integration and Management Center. The single-award contract has a one-year base period of performance, four one-year options, and two one-year performance-based term periods. Work will be performed primarily at MacDill Air Force Base in Tampa, Florida, CENTCOM Forward Headquarters in Doha, Qatar, and in multiple international locations as required.
|
AMZN | Hot Stocks06:27 EDT Amazon launches Amazon Spark shoppable feed, TechCrunch reports - Amazon has launched Amazon Spark, which is available as a feature on the mobile app on iOS, where users can post stories, ideas and images of products they love, which others can react to with comments and "smiles," TechCrunch reports. Amazon had been quietly testing Amazon Spark in beta for a few months, with a goal to shift some of the social activity around products taking place off-site back to Amazon, the report says. Reference Link
|
SSNLF | Hot Stocks06:22 EDT Samsung expands Bixby voice capabilities in U.S. English - Samsung is taking another step forward towards helping people get more out of their connected lives by introducing Bixby voice capabilities for U.S. English in the United States and Korea. Bixby's added functionality will let users seamlessly navigate their phones and easily switch between voice commands, touch, vision and text. Bixby is an intelligent interface available on the Galaxy S8 and S8+ that makes interacting with your device, services and apps more instinctive and seamless. At launch, Bixby will be fully integrated across core Samsung apps. Support for additional native and third-party apps will be available via Bixby Labs, which includes select applications that are offering preliminary integration with Bixby. Because Bixby is deeply integrated into the device - rather than in a standalone application - users can easily switch between voice, touch or text commands. The Fly notes that in June, Axios said Samsung was ready to launch its twice-delayed Bixby voice assistant in the U.S., but only in preview form for now. The report said Samsung planned to expand Bixby's abilities "over time," including to third-party applications.
|
AAPL | Hot Stocks06:17 EDT Apple names Isabel Ge Mahe as managing director of Greater China - Apple announced that Isabel Ge Mahe, vice president of Wireless Technologies, has been named vice president and managing director of Greater China, reporting to CEO Tim Cook and COO Jeff Williams. In this newly created role, Isabel will provide leadership and coordination across Apple's China-based team. Isabel has led Apple's wireless technologies software engineering teams for nine years, focusing on development of cellular, Wi-Fi, Bluetooth, NFC, location and motion technologies for nearly every Apple product. She has also overseen the engineering teams developing Apple Pay, HomeKit and CarPlay. Isabel will assume her new role, based in Shanghai, later this summer.
|
ESES | Hot Stocks06:05 EDT Eco-Stim Energy promotes Barry Ekstrand to COO - Eco-Stim Energy announced that Barry Ekstrand, the company's Senior Vice President of Operations - North America, has been promoted to COO effective August 1. Ekstrand assumes this new role after helping the company to successfully complete the recent start-up of operations in Oklahoma. Simultaneously, Bobby Chapman, the company's current COO will be stepping down from that role while remaining a member of the company's executive team as Vice President of Corporate Development and M&A.
|
HIMX JPM | Hot Stocks06:03 EDT Himax appoints JPMorgan Chase as new American Depository Receipt bank - Himax (HIMX) appointed JPMorgan (JPM) Chase Bank as the company's American Depository Receipt bank.
|
AKZOY | Hot Stocks06:03 EDT AkzoNobel says CEO Ton Buchner stepping down immediately due to health reasons - AkzoNobel announces today that Chief Executive Ton Buchner steps down with immediate effect due to health reasons. The company has announced Thierry Vanlancker as the new CEO. Ton joined AkzoNobel in 2012. Thierry was most recently head of Specialty Chemicals at AkzoNobel, having joined the company in 2016. A successor for the Head of Specialty Chemicals will be announced in due course.
|
DDAIF | Hot Stocks06:00 EDT Daimler to recall 3M diesel vehicles in Europe to fix emissions - The Daimler Board of Management has approved a comprehensive plan for diesel engines: "The public debate about diesel engines is creating uncertainty - especially for our customers. We have therefore decided on additional measures to reassure drivers of diesel cars and to strengthen confidence in diesel technology," stated Dr. Dieter Zetsche, Chairman of the Board of Management of Daimler AG and Head of Mercedes-Benz Cars. "We are convinced that diesel engines will continue to be a fixed element of the drive-system mix, not least due to their low CO2 emissions." The plan comprises a massive expansion of the current service action for vehicles in customers' hands as well as a rapid market launch of a completely new Diesel engine family. Since March, Mercedes-Benz has offered its customers of compact-class cars an improvement in NOx emissions for one engine version. Approximately 45 percent of those cars have meanwhile been updated. In order to effectively improve the emissions of additional model series, Daimler has now decided to extend the service action to include over three million Mercedes-Benz vehicles. The measures to be taken for nearly all EU5 and EU6 vehicles in Europe will be carried out in close cooperation with the German regulatory authorities. The company is investing about 220 million euros. With an investment of approximately three billion euros, the company has developed a new generation of engines whose exemplary emissions have been confirmed by measurements carried out by independent institutes. Following the market launch of the new four-cylinder OM 654 engine in the new E-Class in 2016, the launch of the modular engine family will now be implemented rapidly across the entire model portfolio.
|
MKC | Hot Stocks05:41 EDT McCormick believes combining brands will drive 'significant' holder value - McCormick notes that it believes the acquisition will drive significant shareholder value. "Enhance McCormick's Scale and Increase Growth Through the Expansion of its Portfolio and Consumer Base: McCormick anticipates that the Hot Sauce Category will continue to see robust growth, and with insight-driven innovation and a passionate and increasing fan base, there are significant opportunities for expansion. The company expects McCormick's growing global millennial household penetration to create substantial upside for Frank's RedHot and the other acquired brands, increasing their respective consumer bases. McCormick also expects revenue synergies as a result of leveraging seasonal Holiday promotions and Grilling events that include other McCormick iconic products like Lawry's, Grill Mates and our other global branded spices, herbs and extracts. Drive Branded Foodservice within our Industrial Segment: In addition to retail, RB Foods' brands have attractive positions across Hot Sauce, Mustard, Crispy Vegetable and BBQ Sauce sold through the U.S. and Canadian Foodservice channels. We expect these products to build upon McCormick's Industrial segment growth by increasing the size of that segment's Foodservice sales by over 50% in the U.S. and Canada. French's and Frank's RedHot are ideal additions to McCormick's tabletop offering and its established products. Leverage our Global Scale: McCormick expects to leverage its international infrastructure, which already includes condiment consumer insight, sales and supply chain expertise, to significantly expand the global presence of Frank's RedHot and French's, which we expect will result in substantial growth and increased household penetration. Realize Significant Cost Synergy Opportunities: As a result of increased scale, McCormick expects to achieve cost synergies of approximately $50 million, the majority of which will be achieved by 2020, with anticipated synergies split between selling, general and administrative expenses and cost of goods sold. Generate Margin Expansion: With the addition of RB Foods' business, McCormick expects to achieve meaningful accretion to its margins and adjusted earnings per share, excluding transaction and integration costs, and will achieve additional favorable impacts following the realization of targeted synergies."
|
MKC RBGLY | Hot Stocks05:39 EDT McCormick to acquire RB Foods from Reckitt Benckiser for $4.2B - McCormick (MKC) announced that it has signed a definitive agreement to acquire Reckitt Benckiser's Food Division, RB Foods, from Reckitt Benckiser (RBGLY) for $4.2B, subject to certain customary purchase price adjustments. The addition of Frank's RedHot Hot Sauce, French's Mustard and other iconic, market-leading products strengthens McCormick's leadership in the attractive Condiments category and advances the company's vision to Bring the Joy of Flavor to Life. Combined pro forma 2017 annual net sales are expected to be approximately $5B with significant margin accretion. McCormick will integrate RB Foods into its Consumer and Industrial segments and will retain the brand names of French's, Frank's RedHot and Cattlemen's. "The acquisition of RB Foods strengthens McCormick's flavor leadership with the addition of the iconic French's and Frank's RedHot brands to our portfolio, which will become our number two and number three brands, respectively," said Lawrence Kurzius, Chairman, President and CEO. "RB Foods' focus on creating products with simple, high-quality ingredients makes it a perfect match for McCormick as we continue to capitalize on the growing consumer interest in healthy, flavorful eating. The addition of Frank's RedHot Hot Sauce, the clear consumer favorite in an attractive and high-growth category, French's Mustard and the other beloved products enables McCormick to become a one-stop shop for condiment, spice and seasoning needs, providing our customers and consumers with an even more diverse and complete flavor product offering. RB Foods' track record of creating market-leading products and its dedicated state-of-the-art manufacturing facility are a strong complementary fit that we expect will strengthen McCormick's business opportunities as we expand our presence in condiments, a core category for the company in the U.S. and internationally."
|
MKC RBGLY | Hot Stocks05:35 EDT McCormick to acquire RB Foods from Reckitt Benckiser for $4.2B
|
FPH | Hot Stocks05:18 EDT Five Point Holdings announces Landmark Village, Mission Village re-approval - FivePoint Holdings welcomed the Los Angeles County Board of Supervisors' re-approval of Landmark Village and Mission Village - the first two villages of the approved Newhall Ranch Specific Plan. The re-approval was necessary due to a 2015 California Supreme Court decision requiring a more detailed analysis of the projects' greenhouse gas emissions, along with additional measures to protect the unarmored threespine stickleback fish during project construction. All other aspects of the County's prior environmental review and approvals were upheld. FivePoint, owner of the Newhall Ranch property, viewed the 2015 Supreme Court decision as an opportunity to set a new standard of environmental sustainability through Net Zero Newhall, the unprecedented commitment to make Newhall Ranch one of the nation's most environmentally sustainable communities, with net zero greenhouse gas emissions.
|